Comparison	O	NOUN	B
with	O	ADP	O
alkaline	B-GENE	NOUN	B
phosphatases	I-GENE	NOUN	I
and	O	CCONJ	O
5	B-GENE	NUM	B
-	I-GENE	PUNCT	O
nucleotidase	I-GENE	NOUN	B


Serum	B-GENE	NOUN	B
gamma	I-GENE	NOUN	I
glutamyltransferase	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
liver	O	NOUN	B
disease	O	NOUN	I
in	O	ADP	O
cattle	O	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
secretory	B-GENE	ADJ	B
HI	I-GENE	NOUN	I
antibodies	I-GENE	NOUN	I
were	O	AUX	O
not	O	PART	O
demonstrated	O	VERB	O
at	O	ADP	O
the	O	DET	O
onset	O	NOUN	B
of	O	ADP	I
illness	O	NOUN	B
in	O	ADP	O
any	O	DET	O
of	O	ADP	O
the	O	DET	O
patients	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
their	O	PRON	O
formation	O	NOUN	B
started	O	VERB	O
early	O	ADV	B
and	O	CCONJ	O
the	O	DET	O
antibodies	O	NOUN	B
reached	O	VERB	O
maximal	O	ADJ	B
levels	O	NOUN	B
about	O	ADP	O
10	O	NUM	O
days	O	NOUN	B
after	O	ADP	O
onset	O	NOUN	B
of	O	ADP	I
illness	O	NOUN	I
.	O	PUNCT	O


SGPT	B-GENE	NOUN	B
,	O	PUNCT	O
SGOT	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
alkaline	B-GENE	NOUN	B
phosphatase	I-GENE	NOUN	I
concentrations	O	NOUN	B
were	O	AUX	O
essentially	O	ADV	O
normal	O	ADJ	O
in	O	ADP	O
all	O	DET	O
subjects	O	NOUN	B
.	O	PUNCT	O


Gamma	B-GENE	NOUN	B
glutamyl	I-GENE	NOUN	I
transpeptidase	I-GENE	NOUN	I
(	O	PUNCT	O
GGTP	B-GENE	NOUN	B
)	O	PUNCT	O
activity	O	NOUN	B
in	O	ADP	O
the	O	DET	O
seminal	O	ADJ	B
fluid	O	NOUN	I


Studies	O	NOUN	B
on	O	ADP	O
immunoglobulin	B-GENE	NOUN	B
E	I-GENE	NOUN	I
:	O	PUNCT	O
the	O	DET	O
impact	O	NOUN	B
of	O	ADP	O
a	O	DET	O
sojourn	O	NOUN	B
with	O	ADP	O
Professor	O	PROPN	B
Dan	O	PROPN	I
H	O	PROPN	I
.	O	PUNCT	O


Ten	O	NUM	O
out	O	ADJ	B
-	O	PUNCT	O
patients	O	NOUN	B
with	O	ADP	O
pustulosis	O	NOUN	B
palmaris	O	NOUN	I
et	O	X	O
plantaris	O	NOUN	B
were	O	AUX	O
examined	O	VERB	O
with	O	ADP	O
direct	O	ADJ	B
immunofluorescence	O	NOUN	I
(	O	PUNCT	O
IF	O	NOUN	B
)	O	PUNCT	O
technique	O	NOUN	B
for	O	ADP	O
deposition	O	NOUN	B
of	O	ADP	O
fibrinogen	B-GENE	NOUN	B
,	O	PUNCT	O
fibrin	B-GENE	NOUN	B
or	O	CCONJ	O
its	O	PRON	O
degradation	O	NOUN	B
products	O	NOUN	I
(	O	PUNCT	O
FR	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
antigen	I-GENE	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
affected	O	VERB	B
and	O	CCONJ	O
unaffected	O	ADJ	B
skin	O	NOUN	B
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
heparin	O	NOUN	B
-	O	PUNCT	O
precipitable	O	ADJ	B
fraction	O	NOUN	O
(	O	PUNCT	O
HPF	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
cryoglobulin	B-GENE	NOUN	B
and	O	CCONJ	O
total	O	ADJ	O
plasma	O	NOUN	O
fibrinogen	B-GENE	NOUN	O
in	O	ADP	O
the	O	DET	O
blood	O	NOUN	B
.	O	PUNCT	O


A	O	DET	O
mixture	O	NOUN	O
of	O	ADP	O
human	B-GENE	ADJ	B
albumin	I-GENE	NOUN	O
5	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
hydroxy	O	ADJ	B
-	O	PUNCT	O
ethyl	O	NOUN	B
-	O	PUNCT	O
starch	O	NOUN	B
was	O	AUX	O
used	O	VERB	O
as	O	ADP	O
a	O	DET	O
solution	O	NOUN	B
for	O	ADP	O
dilution	O	NOUN	B
.	O	PUNCT	O


Albumin	B-GENE	NOUN	B
and	O	CCONJ	O
cyclic	O	ADJ	B
AMP	O	NOUN	B
levels	O	NOUN	B
in	O	ADP	O
peritoneal	O	ADJ	B
fluids	O	NOUN	I
in	O	ADP	O
the	O	DET	O
child	O	NOUN	B


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
factor	B-GENE	NOUN	I
IX	I-GENE	NUM	I
activity	O	NOUN	I
is	O	AUX	O
decreased	O	VERB	B
in	O	ADP	O
coumarin	O	NOUN	B
treatment	O	NOUN	B
with	O	ADP	O
factor	B-GENE	NOUN	B
IX	I-GENE	NUM	I
antigen	O	NOUN	I
remaining	O	VERB	O
normal	O	ADJ	B
.	O	PUNCT	O


Aspirin	O	NOUN	B
intolerance	O	NOUN	B
:	O	PUNCT	O
unaltered	O	ADJ	B
susceptibility	O	NOUN	B
of	O	ADP	O
platelet	B-GENE	NOUN	B
cyclo	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
oxygenase	I-GENE	NOUN	B
to	O	PART	O
inhibition	O	NOUN	B
by	O	ADP	O
aspirin	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Native	O	ADJ	B
human	B-GENE	ADJ	B
fibrinogen	I-GENE	NOUN	O
was	O	AUX	O
brought	O	VERB	O
to	O	PART	O
coagulation	O	NOUN	B
by	O	ADP	O
adding	O	VERB	O
thrombin	B-GENE	NOUN	B
.	O	PUNCT	O


Ectopic	O	ADJ	B
ACTH	B-GENE	NOUN	I
syndrome	O	NOUN	I
and	O	CCONJ	O
medullary	O	ADJ	B
thyroid	O	NOUN	I
carcinoma	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
striking	O	ADJ	O
finding	O	NOUN	B
in	O	ADP	O
all	O	DET	O
of	O	ADP	O
the	O	DET	O
studies	O	NOUN	B
was	O	AUX	O
a	O	DET	O
positive	O	ADJ	B
correlation	O	NOUN	B
between	O	ADP	O
PI	O	NOUN	B
ACTH	B-GENE	NOUN	B
and	O	CCONJ	O
MSH	B-GENE	NOUN	B
contents	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
incidence	O	NOUN	B
of	O	ADP	O
hepatitis	B-GENE	NOUN	B
B	I-GENE	NOUN	I
antigen	I-GENE	NOUN	I
following	O	VERB	O
transfusion	O	NOUN	B
was	O	AUX	O
about	O	ADV	O
2	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
per	O	ADP	O
cent	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
decline	O	NOUN	B
in	O	ADP	O
the	O	DET	O
activity	O	NOUN	B
of	O	ADP	O
cytochrome	B-GENE	NOUN	B
oxidase	I-GENE	NOUN	I
,	O	PUNCT	O
peroxidase	B-GENE	NOUN	B
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
lipid	O	NOUN	B
content	O	NOUN	B
of	O	ADP	O
peripheral	O	ADJ	B
neutrophils	O	NOUN	B
was	O	AUX	O
followed	O	VERB	O
by	O	ADP	O
a	O	DET	O
decrease	O	NOUN	B
in	O	ADP	O
the	O	DET	O
phagocytic	O	ADJ	B
activity	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
both	O	CCONJ	O
these	O	DET	O
respects	O	NOUN	O
,	O	PUNCT	O
however	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
DBP	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
resembles	O	VERB	O
the	O	DET	O
late	O	ADJ	B
messengers	O	NOUN	I
of	O	ADP	O
SV40	O	NOUN	B
and	O	CCONJ	O
polyoma	O	NOUN	B
viruses	O	NOUN	I
.	O	PUNCT	O


Serum	B-GENE	NOUN	B
ACTH	I-GENE	NOUN	I
did	O	AUX	O
not	O	PART	O
respond	O	VERB	O
to	O	PART	O
insulin	B-GENE	NOUN	B
and	O	CCONJ	O
metyrapone	O	NOUN	B
.	O	PUNCT	O


Gamma	B-GENE	NOUN	B
glutamyl	I-GENE	NOUN	I
transpeptidase	I-GENE	NOUN	I
activity	O	NOUN	I
was	O	AUX	O
increased	O	VERB	B
up	O	ADV	O
to	O	PART	O
15	O	NUM	O
times	O	NOUN	O
above	O	ADP	O
the	O	DET	O
upper	O	ADJ	B
normal	O	ADJ	I
limit	O	NOUN	I
in	O	ADP	O
children	O	NOUN	B
,	O	PUNCT	O
who	O	PRON	O
received	O	VERB	O
aminopyrine	O	NOUN	B
for	O	ADP	O
two	O	NUM	O
weeks	O	NOUN	B
or	O	CCONJ	O
longer	O	ADV	B
.	O	PUNCT	O


The	O	DET	O
sequences	O	NOUN	B
following	O	VERB	O
the	O	DET	O
X	O	NOUN	B
.	O	PUNCT	O
borealis	O	ADJ	B
oocyte	O	NOUN	I
and	O	CCONJ	O
somatic	O	ADJ	B
5S	B-GENE	NOUN	B
genes	I-GENE	NOUN	I
are	O	AUX	O
identical	O	ADJ	B
in	O	ADP	O
12	O	NUM	O
of	O	ADP	O
the	O	DET	O
first	O	ADJ	O
14	O	NUM	O
residues	O	NOUN	B
and	O	CCONJ	O
contain	O	VERB	O
two	O	NUM	O
or	O	CCONJ	O
more	O	ADJ	O
T	O	NOUN	B
clusters	O	NOUN	I
,	O	PUNCT	O
as	O	ADP	O
does	O	AUX	O
the	O	DET	O
corresponding	O	ADJ	O
region	O	NOUN	O
of	O	ADP	O
X	B-GENE	NOUN	B
.	I-GENE	PUNCT	O
laevis	I-GENE	ADJ	B
oocyte	I-GENE	NOUN	B
5S	I-GENE	NOUN	B
DNA	I-GENE	NOUN	I
.	O	PUNCT	O


High	O	ADJ	O
levels	O	NOUN	B
of	O	ADP	O
serum	O	NOUN	B
calcitonin	B-GENE	NOUN	I
were	O	AUX	O
found	O	VERB	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
chronic	O	ADJ	B
renal	O	ADJ	I
failure	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
response	O	NOUN	B
of	O	ADP	O
serum	B-GENE	NOUN	O
GH	I-GENE	NOUN	B
to	O	PART	O
arginine	O	NOUN	B
infusion	O	NOUN	B
was	O	AUX	O
normal	O	ADJ	B
,	O	PUNCT	O
while	O	SCONJ	O
that	O	DET	O
to	O	PART	O
insulin	B-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
hypoglycemia	O	NOUN	B
was	O	AUX	O
poor	O	ADJ	B
.	O	PUNCT	O


Hepatic	O	ADJ	B
oxygen	O	NOUN	I
supply	O	NOUN	I
and	O	CCONJ	O
selected	O	VERB	O
blood	O	NOUN	B
parameters	O	NOUN	I
were	O	AUX	O
recorded	O	VERB	O
in	O	ADP	O
fasted	O	VERB	B
male	O	NOUN	B
rates	O	NOUN	B
given	O	VERB	O
20	O	NUM	O
-	O	PUNCT	O
-	O	PUNCT	O
30	O	NUM	O
mg	O	NOUN	O
/	O	SYM	O
kg	O	NOUN	B
Escherichia	B-GENE	X	B
coli	I-GENE	X	I
endotoxin	I-GENE	NOUN	B
intraperitoneally	O	ADV	B
.	O	PUNCT	O


Basal	O	ADJ	B
FSH	B-GENE	NOUN	B
and	O	CCONJ	O
LH	B-GENE	NOUN	B
levels	O	NOUN	B
were	O	AUX	O
significantly	O	ADV	O
lower	O	ADJ	O
in	O	ADP	O
addicts	O	NOUN	B
;	O	PUNCT	O
after	O	ADP	O
GnRH	B-GENE	NOUN	B
stimulation	O	NOUN	B
the	O	DET	O
addicts	O	NOUN	B
'	O	PART	O
FSH	B-GENE	NOUN	B
and	O	CCONJ	O
LH	B-GENE	NOUN	B
values	O	NOUN	B
increased	O	VERB	B
but	O	CCONJ	O
not	O	PART	O
significantly	O	ADV	O
compared	O	VERB	O
to	O	PART	O
controls	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
this	O	DET	O
article	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
clinical	O	ADJ	B
actions	O	NOUN	I
of	O	ADP	O
the	O	DET	O
principal	O	ADJ	B
dopamine	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
stimulating	O	NOUN	O
agents	O	NOUN	O
(	O	PUNCT	O
apomorphine	O	NOUN	B
and	O	CCONJ	O
its	O	PRON	O
derivatives	O	NOUN	B
;	O	PUNCT	O
piribedil	O	NOUN	B
,	O	PUNCT	O
rye	O	NOUN	B
-	O	PUNCT	O
ergot	O	NOUN	B
derivatives	O	NOUN	I
)	O	PUNCT	O
are	O	AUX	O
discussed	O	VERB	O
on	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
their	O	PRON	O
biochemical	O	ADJ	B
and	O	CCONJ	O
pharmacological	O	ADJ	B
properties	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
inhibition	O	NOUN	B
of	O	ADP	O
pepsin	B-GENE	NOUN	B
in	O	ADP	O
human	O	ADJ	B
gastric	O	ADJ	B
juice	O	NOUN	I
does	O	AUX	O
not	O	PART	O
appear	O	VERB	O
to	O	PART	O
have	O	AUX	O
a	O	DET	O
major	O	ADJ	O
influence	O	NOUN	B
on	O	ADP	O
the	O	DET	O
healing	O	NOUN	B
of	O	ADP	O
duodenal	O	ADJ	B
ulcer	O	NOUN	I
.	O	PUNCT	O


Plasma	O	NOUN	B
ion	O	NOUN	O
changes	O	NOUN	B
in	O	ADP	O
venous	O	ADJ	B
blood	O	NOUN	I
incubated	O	VERB	B
with	O	ADP	O
beta	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
blockers	O	NOUN	I
and	O	CCONJ	O
subjected	O	VERB	O
to	O	ADP	O
tonometry	O	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Such	O	ADJ	O
marked	O	ADJ	O
differences	O	NOUN	B
are	O	AUX	O
found	O	VERB	O
occasionally	O	ADV	O
in	O	ADP	O
the	O	DET	O
literature	O	NOUN	B
:	O	PUNCT	O
heterophile	O	NOUN	B
antibodies	O	NOUN	I
against	O	ADP	O
bovine	B-GENE	ADJ	B
gammaglobulin	I-GENE	NOUN	I
are	O	AUX	O
regarded	O	VERB	O
as	O	ADP	O
responsible	O	ADJ	O
for	O	ADP	O
the	O	DET	O
interference	O	NOUN	B
in	O	ADP	O
the	O	DET	O
Sephadex	O	NOUN	B
system	O	NOUN	I
of	O	ADP	O
RIST	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
preferential	O	ADJ	O
serum	B-GENE	NOUN	B
IgA	I-GENE	NOUN	O
response	O	NOUN	O
observed	O	VERB	B
in	O	ADP	O
the	O	DET	O
patient	O	NOUN	B
population	O	NOUN	I
suggests	O	VERB	O
that	O	SCONJ	O
bronchial	O	ADJ	B
associated	O	VERB	O
lymphoid	O	ADJ	B
tissue	O	NOUN	I
in	O	ADP	O
the	O	DET	O
diseased	O	ADJ	B
lung	O	NOUN	B
is	O	AUX	O
an	O	DET	O
important	O	ADJ	O
source	O	NOUN	B
of	O	ADP	O
circulating	O	VERB	B
IgA	B-GENE	NOUN	B
.	O	PUNCT	O


A	O	DET	O
rise	O	NOUN	O
of	O	ADP	O
hemoglobin	B-GENE	NOUN	B
concentration	O	NOUN	I
accompanied	O	VERB	O
by	O	ADP	O
an	O	DET	O
increase	O	NOUN	B
of	O	ADP	O
the	O	DET	O
total	O	ADJ	O
iron	O	NOUN	B
in	O	ADP	O
the	O	DET	O
blood	O	NOUN	B
serum	O	NOUN	I
of	O	ADP	O
white	O	ADJ	B
mice	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
under	O	ADP	O
oxygen	O	NOUN	B
pressure	O	NOUN	I
of	O	ADP	O
4	O	NUM	O
atm	O	NOUN	O
for	O	ADP	O
an	O	DET	O
hour	O	NOUN	B
(	O	PUNCT	O
preconvulsive	O	ADJ	B
state	O	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
6	O	NUM	O
atm	O	NOUN	O
(	O	PUNCT	O
convulsive	O	ADJ	B
state	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


It	O	PRON	O
is	O	AUX	O
concluded	O	VERB	O
that	O	SCONJ	O
opiate	B-GENE	ADJ	B
receptors	I-GENE	NOUN	I
bordering	O	VERB	O
the	O	DET	O
fourth	O	ADJ	O
cerebral	O	ADJ	B
ventricle	O	NOUN	I
mediate	O	VERB	O
the	O	DET	O
cardiovascular	O	ADJ	B
and	O	CCONJ	O
hypnotic	O	ADJ	B
action	O	NOUN	I
of	O	ADP	O
fentanyl	O	NOUN	B
.	O	PUNCT	O


Urinary	O	ADJ	B
excretion	O	NOUN	B
of	O	ADP	O
oestrone	O	NOUN	B
,	O	PUNCT	O
oestradiol	O	NOUN	B
-	O	PUNCT	O
17	O	NUM	O
beta	O	NOUN	B
and	O	CCONJ	O
oestriol	O	NOUN	B
in	O	ADP	O
pregnancies	O	NOUN	B
complicated	O	VERB	O
by	O	ADP	O
steroid	B-GENE	NOUN	B
sulphatase	I-GENE	NOUN	I
deficiency	O	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
role	O	NOUN	O
of	O	ADP	O
transferrin	B-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
uptake	O	NOUN	B
of	O	ADP	O
gallium	O	NOUN	B
by	O	ADP	O
tumor	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Screening	O	NOUN	B
of	O	ADP	O
asthma	O	NOUN	B
patients	O	NOUN	B
by	O	ADP	O
determination	O	NOUN	B
of	O	ADP	O
IgE	B-GENE	NOUN	B
and	O	CCONJ	O
by	O	ADP	O
comprehension	O	NOUN	B
of	O	ADP	O
spectrum	O	NOUN	B
of	O	ADP	O
allergospecific	B-GENE	ADJ	B
IgE	I-GENE	NOUN	B
antibodies	I-GENE	NOUN	O


In	O	ADP	O
girls	O	NOUN	B
prolactin	B-GENE	NOUN	B
levels	O	NOUN	I
rise	O	VERB	O
at	O	ADP	O
stage	O	NOUN	B
2	O	NUM	I
,	O	PUNCT	O
and	O	CCONJ	O
are	O	AUX	O
higher	O	ADJ	O
after	O	ADP	O
menarche	O	NOUN	B
;	O	PUNCT	O
in	O	ADP	O
boys	O	NOUN	B
there	O	PRON	O
is	O	AUX	O
no	O	DET	O
change	O	NOUN	O
in	O	ADP	O
prolactin	B-GENE	NOUN	B
levels	O	NOUN	I
.	O	PUNCT	O


Such	O	DET	O
an	O	DET	O
hemoglobin	B-GENE	NOUN	B
solution	O	NOUN	I
was	O	AUX	O
shown	O	VERB	O
to	O	PART	O
exhibit	O	VERB	O
a	O	DET	O
high	O	ADJ	O
affinity	O	NOUN	B
for	O	ADP	O
oxygen	O	NOUN	B
and	O	CCONJ	O
a	O	DET	O
low	O	ADJ	B
Bohr	O	NOUN	B
effect	O	NOUN	I
(	O	PUNCT	O
assessed	O	VERB	B
from	O	ADP	O
the	O	DET	O
delta	O	NOUN	B
log	O	NOUN	I
Po2	O	NOUN	B
/	O	SYM	O
delta	O	NOUN	B
pH	O	NOUN	B
ratio	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


A	O	DET	O
decrease	O	NOUN	B
of	O	ADP	O
the	O	DET	O
lysozyme	B-GENE	NOUN	B
activity	O	NOUN	B
coincided	O	VERB	O
with	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
improvement	O	NOUN	I
of	O	ADP	O
the	O	DET	O
bacterial	O	ADJ	B
meningitis	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
multiple	O	ADJ	B
factors	O	NOUN	B
affecting	O	VERB	O
plasma	O	NOUN	B
renin	B-GENE	NOUN	B
activity	O	NOUN	B
in	O	ADP	O
essential	O	ADJ	B
hypertension	O	NOUN	I
.	O	PUNCT	O


Analysis	O	NOUN	B
of	O	ADP	O
liver	O	NOUN	B
biopsy	O	NOUN	I
specimens	O	NOUN	I
from	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
hepatitis	O	NOUN	B
showed	O	VERB	O
a	O	DET	O
large	O	ADJ	O
variation	O	NOUN	B
in	O	ADP	O
the	O	DET	O
mean	O	ADJ	O
iron	O	NOUN	B
content	O	NOUN	I
of	O	ADP	O
the	O	DET	O
liver	O	NOUN	B
ferritin	B-GENE	NOUN	I
molecules	O	NOUN	I
.	O	PUNCT	O


Angiotensin	B-GENE	NOUN	B
effect	O	NOUN	B
in	O	ADP	O
the	O	DET	O
human	O	ADJ	B
kidney	O	NOUN	I
.	O	PUNCT	O


Value	O	NOUN	B
of	O	ADP	O
determination	O	NOUN	B
of	O	ADP	O
alkaline	B-GENE	NOUN	B
phosphatase	I-GENE	NOUN	I
isoenzymes	I-GENE	NOUN	B
for	O	ADP	O
differential	O	ADJ	B
diagnosis	O	NOUN	I
of	O	ADP	O
obstructive	O	ADJ	B
jaundice	O	NOUN	I
and	O	CCONJ	O
biliary	O	ADJ	B
liver	O	NOUN	I
cirrhosis	O	NOUN	I


Treatment	O	NOUN	B
of	O	ADP	O
hypertension	O	NOUN	B
with	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
the	O	DET	O
adrenergic	B-GENE	ADJ	B
beta	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
blockader	O	NOUN	I
,	O	PUNCT	O
obsidan	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
vasodilator	O	NOUN	B
,	O	PUNCT	O
apressin	O	NOUN	B


Serum	B-GENE	NOUN	B
relaxin	I-GENE	NOUN	B
levels	O	NOUN	O
in	O	ADP	O
prostaglandin	O	NOUN	B
E2	O	NOUN	I
induced	O	ADJ	B
abortions	O	NOUN	B
.	O	PUNCT	O


Carcinoembryonic	B-GENE	NOUN	B
antigen	I-GENE	NOUN	I
(	O	PUNCT	O
CEA	B-GENE	NOUN	B
)	O	PUNCT	O
procedures	O	NOUN	B
and	O	CCONJ	O
clinical	O	ADJ	B
evaluation	O	NOUN	I
.	O	PUNCT	O


Rheumatoid	B-GENE	ADJ	B
factor	I-GENE	NOUN	I
and	O	CCONJ	O
antinuclear	O	ADJ	B
antibody	O	NOUN	I
tests	O	NOUN	I
were	O	AUX	O
frequently	O	ADV	O
positive	O	ADJ	B
,	O	PUNCT	O
and	O	CCONJ	O
reactions	O	NOUN	B
to	O	ADP	O
gold	O	NOUN	B
therapy	O	NOUN	I
were	O	AUX	O
more	O	ADV	O
frequent	O	ADJ	B
than	O	ADP	O
in	O	ADP	O
other	O	ADJ	O
rheumatoid	O	ADJ	B
populations	O	NOUN	I
.	O	PUNCT	O


Recurrence	O	NOUN	B
of	O	ADP	O
bladder	O	NOUN	B
tumors	O	NOUN	I
among	O	ADP	O
the	O	DET	O
original	O	ADJ	B
9	O	NUM	O
cases	O	NOUN	B
has	O	AUX	O
occurred	O	VERB	O
only	O	ADV	O
among	O	ADP	O
the	O	DET	O
5	O	NUM	O
whose	O	DET	O
properdin	B-GENE	NOUN	B
levels	O	NOUN	O
remained	O	VERB	O
below	O	ADP	O
the	O	DET	O
median	O	NOUN	B
.	O	PUNCT	O


Treatment	O	NOUN	B
with	O	ADP	O
heparin	O	NOUN	B
,	O	PUNCT	O
plasminogen	B-GENE	NOUN	B
activators	O	NOUN	I
and	O	CCONJ	O
fibrinogenolytic	O	ADJ	B
agents	O	NOUN	I
was	O	AUX	O
disappointing	O	ADJ	O
although	O	SCONJ	O
renal	O	ADJ	B
function	O	NOUN	I
has	O	AUX	O
stabilized	O	VERB	B
in	O	ADP	O
one	O	NUM	O
patient	O	NOUN	B
on	O	ADP	O
long	O	ADJ	B
term	O	NOUN	I
oral	O	ADJ	B
anticoagulant	O	ADJ	B
therapy	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
morphological	O	ADJ	B
effects	O	NOUN	B
of	O	ADP	O
two	O	NUM	O
snake	O	NOUN	B
venoms	O	NOUN	I
,	O	PUNCT	O
N	O	NOUN	B
.	O	PUNCT	O
naja	O	NOUN	B
and	O	CCONJ	O
A	O	NOUN	B
.	O	PUNCT	O
piscivorus	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
of	O	ADP	O
the	O	DET	O
Direct	B-GENE	ADJ	O
Lytic	I-GENE	ADJ	B
Factor	I-GENE	NOUN	I
and	O	CCONJ	O
Phospholipase	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
A	I-GENE	PROPN	B
,	O	PUNCT	O
compounds	O	NOUN	B
purified	O	VERB	B
from	O	ADP	O
N	O	NOUN	B
.	O	PUNCT	O
naja	O	NOUN	B
crude	O	ADJ	I
venom	O	NOUN	I
,	O	PUNCT	O
were	O	AUX	O
investigated	O	VERB	B
on	O	ADP	O
lung	O	NOUN	B
and	O	CCONJ	O
cremaster	O	NOUN	B
vessels	O	NOUN	I
of	O	ADP	O
rats	O	NOUN	B
.	O	PUNCT	O


Possibility	O	NOUN	B
of	O	ADP	O
a	O	DET	O
TSH	B-GENE	NOUN	B
-	O	PUNCT	O
Screening	O	VERB	B
method	O	NOUN	O
for	O	ADP	O
detection	O	NOUN	B
of	O	ADP	O
hypothyroidism	O	NOUN	B
in	O	ADP	O
the	O	DET	O
newborn	O	ADJ	B


RESULTS	O	NOUN	B
:	O	PUNCT	O
Total	O	ADJ	B
IgE	B-GENE	NOUN	B
levels	O	NOUN	B
showed	O	VERB	O
a	O	DET	O
tendency	O	NOUN	O
to	O	PART	O
diminish	O	VERB	B
.	O	PUNCT	O


The	O	DET	O
neuroleptic	O	ADJ	B
-	O	PUNCT	O
induced	O	VERB	B
increase	O	NOUN	B
in	O	ADP	O
central	O	ADJ	B
DA	O	NOUN	I
turnover	O	NOUN	I
(	O	PUNCT	O
an	O	DET	O
indicator	O	NOUN	B
for	O	ADP	O
the	O	DET	O
degree	O	NOUN	B
of	O	ADP	O
DA	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
blocking	O	NOUN	B
)	O	PUNCT	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
positively	O	ADV	B
correlated	O	VERB	B
with	O	ADP	O
the	O	DET	O
therapeutic	O	ADJ	B
effect	O	NOUN	I
of	O	ADP	O
neuroleptics	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
development	O	NOUN	B
of	O	ADP	O
hypokinetic	O	ADJ	B
-	O	PUNCT	O
rigid	O	ADJ	B
symptoms	O	NOUN	B
.	O	PUNCT	O


Mean	O	VERB	B
corpuscular	B-GENE	ADJ	I
hemoglobin	I-GENE	NOUN	I
concentrations	O	NOUN	I
remained	O	VERB	O
normal	O	ADJ	O
for	O	ADP	O
48	O	NUM	O
h	O	NOUN	O
and	O	CCONJ	O
then	O	ADV	O
decreased	O	VERB	B
in	O	ADP	O
both	O	DET	O
groups	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
CO2	O	NOUN	B
group	O	NOUN	B
showing	O	VERB	O
the	O	DET	O
larger	O	ADJ	O
decrease	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
calcitonin	B-GENE	NOUN	B
,	O	PUNCT	O
a	O	DET	O
large	O	ADJ	O
amount	O	NOUN	O
of	O	ADP	O
calcium	O	NOUN	B
given	O	VERB	O
orally	O	ADV	B
,	O	PUNCT	O
pentagastrin	O	NOUN	B
and	O	CCONJ	O
glucagon	B-GENE	NOUN	B
on	O	ADP	O
plasma	O	NOUN	B
47Ca	O	NOUN	O
radioactivity	O	NOUN	B
curves	O	NOUN	I
in	O	ADP	O
subjects	O	NOUN	B
pretreated	O	VERB	B
with	O	ADP	O
47Ca	O	NOUN	B
was	O	AUX	O
examined	O	VERB	B
.	O	PUNCT	O


Since	O	SCONJ	O
myoglobin	B-GENE	NOUN	B
is	O	AUX	O
co	O	ADV	B
-	O	PUNCT	O
extracted	O	VERB	B
with	O	ADP	O
the	O	DET	O
hemoglobin	B-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
2	O	NUM	O
heme	O	NOUN	B
pigments	O	NOUN	I
are	O	AUX	O
separated	O	VERB	O
in	O	ADP	O
one	O	NUM	O
portion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
extract	O	NOUN	B
by	O	ADP	O
precipitating	O	VERB	B
the	O	DET	O
hemoglobin	B-GENE	NOUN	B
in	O	ADP	O
an	O	DET	O
85	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
NH4	O	NOUN	B
)	O	PUNCT	O
2SO4	O	NOUN	B
solution	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
studies	O	NOUN	B
have	O	AUX	O
shown	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
majority	O	NOUN	O
of	O	ADP	O
tested	O	VERB	B
staphylococci	O	NOUN	B
were	O	AUX	O
resistant	O	ADJ	B
to	O	PART	O
penicillin	O	NOUN	B
G	O	NOUN	I
,	O	PUNCT	O
erythromycin	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
produced	O	VERB	O
beta	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
lactamase	I-GENE	NOUN	B
.	O	PUNCT	O


The	O	DET	O
second	O	ADJ	O
and	O	CCONJ	O
third	O	NOUN	O
responded	O	VERB	O
similarly	O	ADV	O
to	O	PART	O
either	O	CCONJ	O
a	O	DET	O
combined	O	ADJ	O
cyclophosphamide	O	NOUN	B
+	O	CCONJ	O
antilymphocyte	B-GENE	NOUN	B
globulin	I-GENE	NOUN	I
(	O	PUNCT	O
ALG	B-GENE	NOUN	B
)	O	PUNCT	O
treatment	O	NOUN	B
or	O	CCONJ	O
to	O	PART	O
ALG	B-GENE	NOUN	B
administration	O	NOUN	B
preceded	O	VERB	O
by	O	ADP	O
a	O	DET	O
small	O	ADJ	O
dosage	O	NOUN	B
of	O	ADP	O
cyclophosphamide	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
had	O	AUX	O
proved	O	VERB	O
ineffective	O	ADJ	B
when	O	SCONJ	O
administered	O	VERB	B
alone	O	ADV	O
.	O	PUNCT	O


Lymphocyte	O	NOUN	B
subpopulations	O	NOUN	I
,	O	PUNCT	O
serum	B-GENE	NOUN	B
IgE	I-GENE	NOUN	I
and	O	CCONJ	O
total	O	ADJ	O
eosinophil	O	NOUN	O
counts	O	NOUN	O
in	O	ADP	O
patients	O	NOUN	B
with	O	ADP	O
bronchial	O	ADJ	B
asthma	O	NOUN	I
.	O	PUNCT	O


IgG	B-GENE	NOUN	B
levels	O	NOUN	B
of	O	ADP	O
1	O	NUM	O
/	O	SYM	O
100	O	NUM	O
were	O	AUX	O
present	O	ADJ	O
in	O	ADP	O
only	O	ADV	O
four	O	NUM	O
out	O	ADP	O
of	O	ADP	O
ten	O	NUM	O
samples	O	NOUN	B
obtained	O	VERB	O
150	O	NUM	O
days	O	NOUN	B
after	O	ADP	O
the	O	DET	O
clinical	O	ADJ	B
onset	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
other	O	ADJ	O
hypoglycaemic	O	ADJ	B
patient	O	NOUN	B
showed	O	VERB	O
an	O	DET	O
exaggerated	O	ADJ	B
insulin	B-GENE	NOUN	B
release	O	NOUN	O
in	O	ADP	O
response	O	NOUN	B
to	O	PART	O
tolbutamide	O	NOUN	B
.	O	PUNCT	O


Glucose	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	O
-	I-GENE	PUNCT	O
phosphate	I-GENE	NOUN	B
dehydrogenase	I-GENE	NOUN	I
(	O	PUNCT	O
G	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	B
-	I-GENE	PUNCT	O
PD	I-GENE	NOUN	B
)	O	PUNCT	O
deficiency	O	NOUN	B
in	O	ADP	O
the	O	DET	O
newborn	O	ADJ	B
.	O	PUNCT	O


The	O	DET	O
routine	O	ADJ	B
administration	O	NOUN	B
of	O	ADP	O
fat	O	ADJ	B
-	O	PUNCT	O
soluble	O	ADJ	B
vitamins	O	NOUN	B
appears	O	VERB	O
unnecessary	O	ADJ	O
but	O	CCONJ	O
it	O	PRON	O
is	O	AUX	O
prudent	O	ADJ	O
to	O	PART	O
measure	O	VERB	B
prothrombin	B-GENE	NOUN	B
time	O	NOUN	I
and	O	CCONJ	O
serum	O	NOUN	B
vitamins	O	NOUN	I
A	O	NOUN	I
and	O	CCONJ	O
E	O	NOUN	B
at	O	ADP	O
intervals	O	NOUN	B
.	O	PUNCT	O


Association	O	NOUN	B
with	O	ADP	O
HL	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
A	I-GENE	PROPN	O
W	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
27	I-GENE	NUM	O
.	O	PUNCT	O


Generally	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
correlation	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
between	O	ADP	O
highest	O	ADJ	B
concentrations	O	NOUN	B
of	O	ADP	O
CSF	B-GENE	NOUN	B
immunoglobulins	I-GENE	NOUN	B
and	O	CCONJ	O
degree	O	NOUN	B
of	O	ADP	O
meningeal	O	ADJ	B
inflammatory	O	ADJ	O
response	O	NOUN	O
,	O	PUNCT	O
even	O	ADV	O
if	O	SCONJ	O
this	O	DET	O
was	O	AUX	O
a	O	DET	O
component	O	NOUN	B
of	O	ADP	O
other	O	ADJ	O
neurological	O	ADJ	B
diseases	O	NOUN	I
.	O	PUNCT	O


3	O	NUM	O
activities	O	NOUN	B
of	O	ADP	O
the	O	DET	O
factor	B-GENE	NOUN	B
II	I-GENE	NUM	I
molecule	O	NOUN	I
in	O	ADP	O
the	O	DET	O
newborn	O	ADJ	B
infant	O	NOUN	I
at	O	ADP	O
term	O	NOUN	O


One	O	NUM	O
site	O	NOUN	B
,	O	PUNCT	O
PAL	B-GENE	NOUN	B
,	O	PUNCT	O
occurs	O	VERB	O
within	O	ADP	O
the	O	DET	O
10	O	NUM	O
bp	O	NOUN	O
sequence	O	NOUN	O
GGGGAGGAGG	O	NOUN	O
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
describe	O	VERB	O
and	O	CCONJ	O
map	O	VERB	B
two	O	NUM	O
more	O	ADV	O
new	O	ADJ	O
genes	O	NOUN	B
identified	O	VERB	B
as	O	ADP	O
allele	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
suppressors	O	NOUN	B
that	O	PRON	O
compensate	O	VERB	B
for	O	ADP	O
carboxy	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
truncation	O	NOUN	B
of	O	ADP	O
PET122	B-GENE	NOUN	B
.	O	PUNCT	O


Rabbit	B-GENE	VERB	B
skeletal	I-GENE	ADJ	B
muscle	I-GENE	NOUN	I
glycogenin	I-GENE	NOUN	B
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
gene	I-GENE	NOUN	I
encoding	I-GENE	VERB	O
cytokeratin	I-GENE	NOUN	B
17	I-GENE	NUM	I
and	O	CCONJ	O
its	O	PRON	O
expression	O	NOUN	B
pattern	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
statistically	O	ADV	B
significant	O	ADJ	I
improvement	O	NOUN	B
due	O	ADJ	O
to	O	ADP	O
the	O	DET	O
administration	O	NOUN	B
of	O	ADP	O
Bromergon	O	PROPN	B
was	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
symptoms	O	NOUN	B
associated	O	VERB	B
with	O	ADP	I
overreactiveness	O	NOUN	B
to	O	PART	O
normal	O	ADJ	O
prolactin	B-GENE	NOUN	B
levels	O	NOUN	I
,	O	PUNCT	O
i	O	X	O
.	O	PUNCT	O
e	O	X	O
.	O	PUNCT	O
abdominal	O	ADJ	B
tension	O	NOUN	I
,	O	PUNCT	O
edema	O	NOUN	B
,	O	PUNCT	O
weight	O	NOUN	B
gain	O	NOUN	I
and	O	CCONJ	O
breast	O	NOUN	B
tenderness	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
analysis	O	NOUN	B
,	O	PUNCT	O
together	O	ADV	O
with	O	ADP	O
a	O	DET	O
consideration	O	NOUN	O
of	O	ADP	O
the	O	DET	O
SCBs	O	NOUN	B
found	O	VERB	O
upstream	O	ADJ	B
of	O	ADP	O
known	O	VERB	O
SWI4	B-GENE	NOUN	B
,	I-GENE	PUNCT	O
6	I-GENE	NUM	O
-	O	PUNCT	O
dependent	O	ADJ	B
genes	O	NOUN	B
,	O	PUNCT	O
leads	O	VERB	O
to	O	PART	O
the	O	DET	O
proposal	O	NOUN	B
of	O	ADP	O
a	O	DET	O
revised	O	VERB	O
consensus	O	NOUN	B
sequence	O	NOUN	I
for	O	ADP	O
this	O	DET	O
important	O	ADJ	O
regulatory	O	ADJ	B
element	O	NOUN	I
.	O	PUNCT	O


Synergistic	O	ADJ	B
transactivation	O	NOUN	O
of	O	ADP	O
the	O	DET	O
BMRF1	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
by	O	ADP	O
the	O	DET	O
Z	B-GENE	PROPN	B
/	O	SYM	O
c	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
myb	I-GENE	NOUN	B
combination	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
involve	O	VERB	O
direct	O	ADJ	O
binding	O	NOUN	B
by	O	ADP	O
the	O	DET	O
Z	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
but	O	CCONJ	O
not	O	PART	O
the	O	DET	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
myb	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
cellular	O	ADJ	B
sequences	O	NOUN	I
5	O	NUM	O
'	O	PUNCT	O
to	O	PART	O
the	O	DET	O
viral	O	ADJ	B
integration	O	NOUN	I
site	O	NOUN	I
exhibited	O	VERB	O
85	O	NUM	O
to	O	PART	O
97	O	NUM	O
%	O	NOUN	O
identity	O	NOUN	B
to	O	PART	O
several	O	ADJ	O
sequences	O	NOUN	B
belonging	O	VERB	O
to	O	PART	O
the	O	DET	O
mouse	B-GENE	NOUN	B
L1	I-GENE	NOUN	I
family	I-GENE	NOUN	O
of	O	ADP	O
long	O	ADV	B
interspersed	O	ADJ	I
repetitive	O	ADJ	I
sequences	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
predicted	O	VERB	O
receptor	O	NOUN	B
structure	O	NOUN	I
includes	O	VERB	O
a	O	DET	O
cysteine	O	NOUN	B
-	O	PUNCT	O
rich	O	ADJ	B
extracellular	O	ADJ	O
domain	O	NOUN	O
,	O	PUNCT	O
a	O	DET	O
single	O	ADJ	O
hydrophobic	O	ADJ	B
transmembrane	O	ADJ	O
domain	O	NOUN	O
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
predicted	O	VERB	O
cytoplasmic	B-GENE	ADJ	B
serine	I-GENE	NOUN	B
/	I-GENE	PUNCT	O
threonine	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
domain	I-GENE	NOUN	I
.	O	PUNCT	O


Drosophila	B-GENE	X	B
UbcD1	I-GENE	NOUN	B
encodes	O	VERB	O
a	O	DET	O
highly	O	ADV	O
conserved	O	VERB	O
ubiquitin	B-GENE	NOUN	B
-	O	PUNCT	O
conjugating	O	VERB	B
enzyme	O	NOUN	B
involved	O	VERB	O
in	O	ADP	O
selective	O	ADJ	O
protein	O	NOUN	B
degradation	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
goal	O	NOUN	B
of	O	ADP	O
the	O	DET	O
present	O	ADJ	O
study	O	NOUN	B
was	O	AUX	O
to	O	PART	O
determine	O	VERB	O
the	O	DET	O
feasibility	O	NOUN	B
of	O	ADP	O
retrovirus	O	NOUN	B
mediated	O	ADJ	O
expression	O	NOUN	B
of	O	ADP	O
rp47phox	B-GENE	NOUN	B
in	O	ADP	O
the	O	DET	O
HL60	O	NOUN	B
and	O	CCONJ	O
U937	O	NOUN	B
human	O	ADJ	O
hematopoietic	O	ADJ	B
cell	O	NOUN	I
lines	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
in	O	ADP	O
an	O	DET	O
Epstein	O	PROPN	B
-	O	PUNCT	O
Barr	O	PROPN	B
virus	O	NOUN	I
transformed	O	VERB	B
B	O	NOUN	I
-	O	PUNCT	O
lymphocyte	O	NOUN	B
cell	O	NOUN	I
line	O	NOUN	I
(	O	PUNCT	O
EBV	O	NOUN	B
-	O	PUNCT	O
BCL	O	NOUN	B
)	O	PUNCT	O
derived	O	VERB	O
from	O	ADP	O
a	O	DET	O
p47phox	B-GENE	NOUN	B
-	O	PUNCT	O
deficient	O	ADJ	B
CGD	O	NOUN	B
patient	O	NOUN	B
.	O	PUNCT	O


Myogenic	O	ADJ	B
differentiation	O	NOUN	I
can	O	AUX	O
be	O	AUX	O
inhibited	O	VERB	B
by	O	ADP	O
the	O	DET	O
adenovirus	O	NOUN	B
E1a	B-GENE	NOUN	I
protein	I-GENE	NOUN	I
in	O	ADP	O
the	O	DET	O
rat	O	NOUN	B
L6	O	NOUN	B
muscle	O	NOUN	I
cell	O	NOUN	I
line	O	NOUN	I
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
IR5	B-GENE	NOUN	B
ORF	I-GENE	NOUN	I
of	O	ADP	O
EHV	O	PROPN	B
-	O	PUNCT	O
1	O	NUM	O
possesses	O	VERB	O
a	O	DET	O
sequence	O	NOUN	B
of	O	ADP	O
13	O	NUM	O
amino	O	NOUN	B
acids	O	NOUN	I
(	O	PUNCT	O
CAYWCCLGHAFAC	O	NOUN	B
)	O	PUNCT	O
that	O	PRON	O
is	O	AUX	O
a	O	DET	O
perfect	O	ADJ	O
match	O	NOUN	O
to	O	PART	O
the	O	DET	O
consensus	O	NOUN	B
zinc	O	NOUN	B
finger	O	NOUN	I
motif	O	NOUN	O
(	O	PUNCT	O
C	O	NOUN	B
-	O	PUNCT	O
X2	O	NOUN	B
-	O	PUNCT	O
4	O	NUM	O
-	O	PUNCT	O
C	O	PROPN	B
-	O	PUNCT	O
X2	O	NOUN	B
-	O	PUNCT	O
15	O	NUM	O
-	O	PUNCT	O
C	O	PROPN	B
/	O	SYM	O
H	O	PROPN	B
-	O	PUNCT	O
X2	O	NOUN	B
-	O	PUNCT	O
4	O	NUM	O
-	O	PUNCT	O
C	O	PROPN	B
/	O	SYM	O
H	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
results	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
an	O	DET	O
internal	O	ADJ	B
short	O	ADJ	I
element	O	NOUN	I
located	O	ADJ	O
at	O	ADP	O
the	O	DET	O
very	O	ADV	O
5	O	NUM	O
'	O	PART	O
terminal	O	NOUN	B
of	O	ADP	O
L1	B-GENE	NOUN	O
sequence	I-GENE	NOUN	O
and	O	CCONJ	O
the	O	DET	O
nuclear	O	ADJ	B
factor	O	NOUN	I
binding	O	VERB	I
to	O	PART	O
the	O	DET	O
element	O	NOUN	B
play	O	VERB	O
a	O	DET	O
crucial	O	ADJ	O
role	O	NOUN	O
in	O	ADP	O
the	O	DET	O
transcription	O	NOUN	B
of	O	ADP	O
human	B-GENE	ADJ	B
L1	I-GENE	NOUN	O
.	O	PUNCT	O


Tumor	O	NOUN	B
cells	O	NOUN	I
were	O	AUX	O
focally	O	ADV	B
immunoreactive	O	ADJ	I
for	O	ADP	O
neuron	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
specific	I-GENE	ADJ	B
enolase	I-GENE	NOUN	B
,	O	PUNCT	O
insulin	B-GENE	NOUN	B
,	O	PUNCT	O
glucagon	B-GENE	NOUN	B
and	O	CCONJ	O
VIP	B-GENE	NOUN	B
.	O	PUNCT	O


To	O	PART	O
define	O	VERB	O
the	O	DET	O
number	O	NOUN	O
and	O	CCONJ	O
nature	O	NOUN	B
of	O	ADP	O
the	O	DET	O
E6	B-GENE	NOUN	B
and	O	CCONJ	O
E7	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
products	O	NOUN	I
expressed	O	VERB	B
in	O	ADP	O
BPV	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	B
-	O	PUNCT	O
transformed	O	VERB	B
cells	O	NOUN	I
,	O	PUNCT	O
we	O	PRON	O
performed	O	VERB	O
immunoprecipitation	O	NOUN	B
experiments	O	NOUN	B
with	O	ADP	O
antisera	O	NOUN	B
raised	O	VERB	O
to	O	PART	O
bacterially	O	ADV	B
expressed	O	VERB	B
BPV	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
E6	I-GENE	NOUN	B
and	O	CCONJ	O
E7	B-GENE	NOUN	B
fusion	I-GENE	NOUN	I
proteins	I-GENE	NOUN	I
.	O	PUNCT	O


A	O	DET	O
third	O	ADJ	O
prominent	O	ADJ	O
component	O	NOUN	O
of	O	ADP	O
apparent	O	ADJ	B
molecular	O	ADJ	B
mass	O	NOUN	I
16	O	NUM	O
kDa	O	NOUN	O
displayed	O	VERB	O
several	O	ADJ	O
properties	O	NOUN	B
,	O	PUNCT	O
including	O	VERB	O
ability	O	NOUN	O
to	O	PART	O
bind	O	VERB	B
45Ca2	O	NOUN	B
+	O	CCONJ	O
,	O	PUNCT	O
that	O	PRON	O
are	O	AUX	O
characteristic	O	ADJ	O
of	O	ADP	O
the	O	DET	O
regulatory	O	ADJ	B
(	O	PUNCT	O
B	O	NOUN	O
)	O	PUNCT	O
subunit	O	NOUN	O
of	O	ADP	O
mammalian	B-GENE	ADJ	B
calcineurin	I-GENE	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
recognized	O	VERB	O
by	O	ADP	O
an	O	DET	O
antiserum	O	NOUN	B
raised	O	VERB	B
against	O	ADP	O
bovine	B-GENE	ADJ	B
calcineurin	I-GENE	NOUN	O
.	O	PUNCT	O


Antibodies	O	NOUN	B
against	O	ADP	O
this	O	DET	O
purified	O	VERB	O
protein	O	NOUN	O
localize	O	VERB	O
RIM1	B-GENE	NOUN	B
to	O	PART	O
mitochondria	O	NOUN	B
.	O	PUNCT	O


METHODS	O	NOUN	O
:	O	PUNCT	O
IgG	B-GENE	NOUN	B
antibodies	I-GENE	NOUN	I
vs	O	CCONJ	O
HHV	O	NOUN	B
-	O	PUNCT	O
6	O	NUM	O
(	O	PUNCT	O
anti	B-GENE	X	B
-	I-GENE	PUNCT	O
HHV	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
6	I-GENE	NUM	B
-	I-GENE	PUNCT	O
IgG	I-GENE	NOUN	B
)	O	PUNCT	O
were	O	AUX	O
determined	O	VERB	O
by	O	ADP	O
indirect	O	ADJ	B
immunofluorescence	O	NOUN	B
in	O	ADP	O
100	O	NUM	O
IVDA	O	NOUN	B
(	O	PUNCT	O
29	O	NUM	O
seronegative	O	ADJ	B
and	O	CCONJ	O
71	O	NUM	O
seropositive	O	ADJ	B
for	O	ADP	O
HIV	O	NOUN	B
-	O	PUNCT	O
1	O	NUM	O
of	O	ADP	O
which	O	DET	O
45	O	NUM	O
were	O	AUX	O
in	O	ADP	O
stage	O	NOUN	B
II	O	NUM	I
and	O	CCONJ	O
26	O	NUM	O
in	O	ADP	O
IV	O	NUM	B
-	O	PUNCT	O
C1	O	NOUN	B
of	O	ADP	O
CDC	O	PROPN	B
)	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
in	O	ADP	O
100	O	NUM	O
healthy	O	ADJ	B
subjects	O	NOUN	I
of	O	ADP	O
a	O	DET	O
similar	O	ADJ	O
age	O	NOUN	B
(	O	PUNCT	O
control	O	NOUN	B
group	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Possible	O	ADJ	O
roles	O	NOUN	O
of	O	ADP	O
RAD5	B-GENE	NOUN	B
putative	O	ADJ	O
ATPase	B-GENE	NOUN	B
/	O	PUNCT	O
DNA	B-GENE	NOUN	B
helicase	I-GENE	NOUN	I
activity	O	NOUN	O
in	O	ADP	O
DNA	O	NOUN	B
repair	O	NOUN	I
and	O	CCONJ	O
in	O	ADP	O
the	O	DET	O
maintenance	O	NOUN	B
of	O	ADP	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
rates	O	NOUN	B
of	O	ADP	O
instability	O	NOUN	B
of	O	ADP	O
simple	O	ADJ	O
repetitive	O	ADJ	B
sequences	O	NOUN	I
are	O	AUX	O
discussed	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
hit1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
mutation	O	NOUN	B
caused	O	VERB	O
a	O	DET	O
defect	O	NOUN	B
in	O	ADP	O
synthesis	O	NOUN	B
of	O	ADP	O
a	O	DET	O
74	B-GENE	NUM	O
-	I-GENE	PUNCT	O
kD	I-GENE	NOUN	B
heat	I-GENE	NOUN	B
shock	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
319	O	NUM	O
base	O	NOUN	B
pair	O	NOUN	I
region	O	NOUN	I
immediately	O	ADV	O
upstream	O	ADV	B
of	O	ADP	O
the	O	DET	O
CAP	O	NOUN	B
site	O	NOUN	B
is	O	AUX	O
characterized	O	VERB	B
by	O	ADP	O
the	O	DET	O
lack	O	NOUN	B
of	O	ADP	O
a	O	DET	O
proximal	O	ADJ	B
TATA	O	NOUN	O
box	O	NOUN	O
and	O	CCONJ	O
the	O	DET	O
presence	O	NOUN	B
of	O	ADP	O
sequences	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
GC	O	NOUN	B
boxes	O	NOUN	I
,	O	PUNCT	O
CACCC	O	NOUN	B
boxes	O	NOUN	I
,	O	PUNCT	O
CCAAT	O	NOUN	B
boxes	O	NOUN	I
,	O	PUNCT	O
activator	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
2	I-GENE	NUM	I
(	O	PUNCT	O
Ap	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
)	O	PUNCT	O
sites	O	NOUN	B
,	O	PUNCT	O
partial	O	ADJ	B
glucocorticoid	O	NOUN	B
response	O	NOUN	I
elements	O	NOUN	I
(	O	PUNCT	O
GREs	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
partial	O	ADJ	B
cyclic	O	ADJ	B
AMP	O	NOUN	O
response	O	NOUN	O
elements	O	NOUN	O
(	O	PUNCT	O
CREs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


These	O	DET	O
findings	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
MAP	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
activator	I-GENE	NOUN	I
/	O	SYM	O
MAP	B-GENE	NOUN	B
kinase	I-GENE	NOUN	I
system	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
the	O	DET	O
downstream	O	ADJ	B
components	O	NOUN	O
of	O	ADP	O
ras	B-GENE	NOUN	B
signal	O	NOUN	I
transduction	O	NOUN	I
pathways	O	NOUN	I
.	O	PUNCT	O


NSCL	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
a	O	DET	O
larger	O	ADJ	O
number	O	NOUN	O
of	O	ADP	O
these	O	DET	O
cell	O	NOUN	B
lines	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
single	O	ADJ	O
MEF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
site	I-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
major	O	ADJ	O
positive	O	ADJ	B
regulatory	O	ADJ	B
element	O	NOUN	I
required	O	VERB	O
for	O	ADP	O
transcription	O	NOUN	B
of	O	ADP	O
the	O	DET	O
muscle	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
subunit	O	NOUN	B
of	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
phosphoglycerate	I-GENE	NOUN	O
mutase	I-GENE	NOUN	O
gene	I-GENE	NOUN	O
in	O	ADP	O
skeletal	O	ADJ	B
and	O	CCONJ	O
cardiac	O	ADJ	B
muscle	O	NOUN	I
cells	O	NOUN	I
.	O	PUNCT	O


Intermediate	O	ADJ	B
levels	O	NOUN	O
of	O	ADP	O
gene	O	NOUN	B
activity	O	NOUN	I
were	O	AUX	O
observed	O	VERB	O
for	O	ADP	O
TnI	B-GENE	NOUN	B
enhancers	I-GENE	NOUN	B
containing	O	VERB	O
E	O	NOUN	B
-	O	PUNCT	O
boxes	O	NOUN	B
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
MCK	B-GENE	NOUN	B
left	I-GENE	VERB	B
E	I-GENE	PROPN	I
-	I-GENE	PUNCT	O
box	I-GENE	NOUN	B
site	I-GENE	NOUN	I
or	O	CCONJ	O
from	O	ADP	O
the	O	DET	O
Ig	B-GENE	NOUN	B
kappa	I-GENE	NOUN	I
E2	I-GENE	NOUN	I
E	I-GENE	PROPN	I
-	I-GENE	PUNCT	O
box	I-GENE	NOUN	B
.	O	PUNCT	O


T	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
cell	I-GENE	NOUN	B
receptor	I-GENE	NOUN	I
beta	I-GENE	NOUN	I
(	O	PUNCT	I
TCR	B-GENE	NOUN	O
beta	I-GENE	NOUN	O
)	O	PUNCT	O
gene	O	NOUN	B
rearrangements	O	NOUN	I
occur	O	VERB	O
in	O	ADP	O
a	O	DET	O
third	O	NOUN	O
of	O	ADP	O
early	O	ADJ	B
B	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
acute	O	ADJ	B
lymphoblastic	O	ADJ	I
leukemias	O	NOUN	I
(	O	PUNCT	O
ALLs	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
cloned	O	VERB	B
and	O	CCONJ	O
sequenced	O	VERB	B
COX12	B-GENE	NOUN	B
,	O	PUNCT	O
the	O	DET	O
nuclear	O	ADJ	B
gene	O	NOUN	I
for	O	ADP	O
subunit	B-GENE	NOUN	B
VIb	I-GENE	NOUN	I
of	O	ADP	O
Saccharomyces	B-GENE	X	B
cerevisiae	I-GENE	X	I
cytochrome	I-GENE	NOUN	B
c	I-GENE	NOUN	I
oxidase	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
basal	O	ADJ	B
promoter	O	NOUN	O
elements	O	NOUN	O
of	O	ADP	O
murine	B-GENE	ADJ	B
cytochrome	I-GENE	NOUN	B
c	I-GENE	NOUN	I
oxidase	I-GENE	NOUN	I
subunit	I-GENE	NOUN	I
IV	I-GENE	NUM	I
gene	I-GENE	NOUN	O
consist	O	VERB	O
of	O	ADP	O
tandemly	O	ADJ	B
duplicated	O	ADJ	O
ets	B-GENE	NOUN	B
motifs	O	NOUN	I
that	O	PRON	O
bind	O	VERB	B
to	O	PART	O
GABP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
transcription	I-GENE	NOUN	B
factors	I-GENE	NOUN	I
.	O	PUNCT	O


Mapping	O	VERB	B
the	O	DET	O
cAMP	B-GENE	NOUN	B
receptor	I-GENE	NOUN	I
protein	I-GENE	NOUN	I
contact	I-GENE	NOUN	B
site	I-GENE	NOUN	I
on	O	ADP	O
the	O	DET	O
alpha	O	NOUN	B
subunit	O	NOUN	I
of	O	ADP	O
Escherichia	B-GENE	X	B
coli	I-GENE	X	I
RNA	I-GENE	NOUN	B
polymerase	I-GENE	NOUN	I
.	O	PUNCT	O


A	O	DET	O
major	O	ADJ	O
mechanism	O	NOUN	B
whereby	O	SCONJ	O
steroid	B-GENE	NOUN	B
hydroxylase	I-GENE	NOUN	I
gene	I-GENE	NOUN	B
transcription	O	NOUN	I
is	O	AUX	O
regulated	O	VERB	O
in	O	ADP	O
the	O	DET	O
adrenal	O	ADJ	B
cortex	O	NOUN	I
requires	O	VERB	O
the	O	DET	O
pituitary	O	ADJ	B
peptide	O	NOUN	I
hormone	O	NOUN	I
,	O	PUNCT	O
ACTH	B-GENE	NOUN	B
,	O	PUNCT	O
which	O	DET	O
acts	O	VERB	O
via	O	ADP	O
cAMP	O	NOUN	B
.	O	PUNCT	O


Structure	O	NOUN	B
and	O	CCONJ	O
expression	O	NOUN	B
of	O	ADP	O
a	O	DET	O
gene	O	NOUN	B
from	O	ADP	O
Arabidopsis	O	NOUN	B
thaliana	O	NOUN	I
encoding	O	VERB	B
a	O	DET	O
protein	O	NOUN	B
related	O	ADJ	O
to	O	PART	O
SNF1	B-GENE	NOUN	B
protein	O	NOUN	I
kinase	O	NOUN	I
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
cloned	O	VERB	B
and	O	CCONJ	O
characterized	O	VERB	B
a	O	DET	O
55	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	B
region	O	NOUN	I
of	O	ADP	O
DNA	O	NOUN	B
surrounding	O	VERB	O
HRAS1	B-GENE	NOUN	B
.	O	PUNCT	O


An	O	DET	O
RNA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
binding	I-GENE	VERB	B
protein	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
(	O	PUNCT	O
rbp1	B-GENE	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
Drosophila	O	X	B
melanogaster	O	X	I
,	O	PUNCT	O
encoding	O	VERB	B
an	O	DET	O
RNA	O	NOUN	B
recognition	O	NOUN	I
motif	O	NOUN	I
and	O	CCONJ	O
an	O	DET	O
Arg	O	NOUN	B
-	O	PUNCT	O
Ser	O	NOUN	B
rich	O	ADJ	O
(	O	PUNCT	O
RS	O	NOUN	B
)	O	PUNCT	O
domain	O	NOUN	B
,	O	PUNCT	O
has	O	AUX	O
been	O	AUX	O
characterized	O	VERB	B
.	O	PUNCT	O


This	O	DET	O
mutation	O	NOUN	B
also	O	ADV	O
results	O	VERB	B
in	O	ADP	O
markedly	O	ADV	O
decreased	O	VERB	B
levels	O	NOUN	B
of	O	ADP	O
CAD	B-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
and	O	CCONJ	O
protein	O	NOUN	B
in	O	ADP	O
the	O	DET	O
mutant	O	NOUN	B
.	O	PUNCT	O


Thus	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
pol	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
-	O	PUNCT	O
primase	B-GENE	NOUN	B
complex	O	NOUN	B
appears	O	VERB	O
to	O	PART	O
act	O	VERB	O
processively	O	ADV	B
for	O	ADP	O
only	O	ADV	O
a	O	DET	O
short	O	ADJ	B
distance	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
a	O	DET	O
retrospective	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
data	O	NOUN	B
from	O	ADP	O
35	O	NUM	O
cases	O	NOUN	B
with	O	ADP	O
malignant	O	ADJ	B
lymphoma	O	NOUN	I
from	O	ADP	O
a	O	DET	O
cohort	O	NOUN	B
of	O	ADP	O
2017	O	NUM	O
HIV	O	NOUN	B
-	O	PUNCT	O
infected	O	VERB	B
patients	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
stage	O	NOUN	B
of	O	ADP	O
HIV	O	NOUN	B
-	O	PUNCT	O
disease	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
CD4	B-GENE	NOUN	B
counts	O	VERB	I
at	O	ADP	O
the	O	DET	O
time	O	NOUN	B
of	O	ADP	O
diagnosis	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
use	O	NOUN	O
of	O	ADP	O
antineoplastic	O	ADJ	B
agents	O	NOUN	I
or	O	CCONJ	O
radiotherapy	O	NOUN	B
were	O	AUX	O
correlated	O	VERB	B
with	O	ADP	O
outcome	O	NOUN	B
.	O	PUNCT	O


cDNA	O	NOUN	B
clones	O	NOUN	I
encoding	O	VERB	B
Arabidopsis	O	NOUN	B
thaliana	O	NOUN	I
and	O	CCONJ	O
Zea	B-GENE	NOUN	B
mays	I-GENE	X	I
mitochondrial	I-GENE	ADJ	B
chaperonin	I-GENE	NOUN	B
HSP60	B-GENE	NOUN	B
and	O	CCONJ	O
gene	O	NOUN	B
expression	O	NOUN	I
during	O	ADP	O
seed	O	NOUN	B
germination	O	NOUN	I
and	O	CCONJ	O
heat	O	NOUN	B
shock	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
subunit	O	NOUN	B
protein	O	NOUN	I
of	O	ADP	O
curli	B-GENE	NOUN	B
was	O	AUX	O
highly	O	ADV	O
homologous	O	ADJ	B
at	O	ADP	O
its	O	PRON	O
amino	O	NOUN	B
terminus	O	NOUN	I
to	O	PART	O
SEF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
17	I-GENE	NUM	O
,	O	PUNCT	O
the	O	DET	O
subunit	O	NOUN	B
protein	O	NOUN	I
of	O	ADP	I
thin	O	ADJ	I
,	O	PUNCT	O
aggregative	O	ADJ	B
fimbriae	O	NOUN	B
of	O	ADP	O
Salmonella	O	X	B
enteritidis	O	X	I
27655	O	NUM	I
strain	O	NOUN	B
3b	O	NOUN	I
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
these	O	DET	O
fibres	O	NOUN	B
form	O	VERB	O
a	O	DET	O
novel	O	ADJ	B
class	O	NOUN	O
of	O	ADP	O
surface	O	NOUN	B
organelles	O	NOUN	B
on	O	ADP	O
enterobacteria	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
distal	O	ADJ	B
portion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
rat	B-GENE	NOUN	B
insulin	I-GENE	NOUN	B
I	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
5	I-GENE	NUM	I
'	I-GENE	PUNCT	O
-	I-GENE	PUNCT	O
flanking	I-GENE	ADJ	B
DNA	I-GENE	NOUN	B
contains	O	VERB	O
two	O	NUM	O
sequence	O	NOUN	B
elements	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
Far	O	PROPN	B
and	O	CCONJ	O
FLAT	O	NOUN	B
elements	O	NOUN	O
,	O	PUNCT	O
that	O	PRON	O
can	O	AUX	O
function	O	VERB	B
in	O	ADP	O
combination	O	NOUN	B
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
separately	O	ADV	O
,	O	PUNCT	O
as	O	ADP	O
a	O	DET	O
beta	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
transcriptional	O	ADJ	B
enhancer	O	NOUN	I
.	O	PUNCT	O


Finally	O	ADV	O
,	O	PUNCT	O
we	O	PRON	O
determined	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
P68	B-GENE	NOUN	B
amino	O	NOUN	I
terminus	O	NOUN	I
was	O	AUX	O
both	O	CCONJ	O
necessary	O	ADJ	O
and	O	CCONJ	O
sufficient	O	ADJ	B
for	O	ADP	O
binding	O	VERB	B
dsRNA	O	NOUN	B
as	O	ADP	O
we	O	PRON	O
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
transfer	O	VERB	O
dsRNA	O	NOUN	B
-	O	PUNCT	O
binding	O	NOUN	B
properties	O	NOUN	B
to	O	PART	O
a	O	DET	O
reporter	O	NOUN	B
gene	O	NOUN	I
product	O	NOUN	I
previously	O	ADV	O
unable	O	ADJ	O
to	O	PART	O
bind	O	VERB	B
RNA	O	NOUN	B
.	O	PUNCT	O


Visual	O	ADJ	B
acuity	O	NOUN	I
may	O	AUX	O
be	O	AUX	O
decreased	O	VERB	B
by	O	ADP	O
transient	O	ADJ	B
changes	O	NOUN	B
in	O	ADP	O
refractive	O	ADJ	B
error	O	NOUN	I
caused	O	VERB	O
by	O	ADP	O
sulfonamides	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
antifungal	O	ADJ	B
agent	O	NOUN	I
metronidazole	O	NOUN	B
,	O	PUNCT	O
thiazide	O	NOUN	B
diuretics	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
carbonic	B-GENE	ADJ	B
anhydrase	I-GENE	NOUN	I
inhibitors	O	NOUN	I
.	O	PUNCT	O


Perturbation	O	NOUN	B
of	O	ADP	O
dNTP	O	NOUN	B
pools	O	NOUN	O
also	O	ADV	O
affected	O	VERB	B
the	O	DET	O
frameshift	O	NOUN	B
fidelity	O	NOUN	B
of	O	ADP	O
the	O	DET	O
replicative	O	ADJ	B
yeast	B-GENE	NOUN	O
DNA	I-GENE	NOUN	O
polymerase	I-GENE	NOUN	O
alpha	I-GENE	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
hGCSFR	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
was	O	AUX	O
chromosomally	O	ADV	B
localized	O	VERB	I
by	O	ADP	O
Southern	O	NOUN	B
blot	O	NOUN	I
analysis	O	NOUN	I
of	O	ADP	O
its	O	PRON	O
segregation	O	NOUN	B
pattern	O	NOUN	B
in	O	ADP	O
a	O	DET	O
panel	O	NOUN	O
of	O	ADP	O
rodent	O	ADJ	B
-	O	PUNCT	O
human	O	ADJ	B
hybrid	O	NOUN	B
DNAs	O	NOUN	I
using	O	VERB	O
the	O	DET	O
radiolabeled	O	VERB	B
cDNA	O	NOUN	B
probe	O	NOUN	I
.	O	PUNCT	O


These	O	DET	O
exons	O	NOUN	B
,	O	PUNCT	O
further	O	ADV	O
identified	O	VERB	O
as	O	ADP	O
exons	O	NOUN	B
9	O	NUM	O
,	O	PUNCT	O
10	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
11	O	NUM	O
,	O	PUNCT	O
together	O	ADV	O
encode	O	VERB	B
the	O	DET	O
37	O	NUM	O
amino	O	NOUN	B
acid	O	NOUN	I
residues	O	NOUN	I
present	O	ADJ	O
in	O	ADP	O
alpha	B-GENE	NOUN	B
s1	I-GENE	ADJ	I
-	I-GENE	PUNCT	O
casein	I-GENE	NOUN	B
variant	I-GENE	NOUN	B
A	I-GENE	NOUN	I
but	O	CCONJ	O
missing	O	VERB	O
in	O	ADP	O
variant	O	ADJ	B
F	O	PROPN	I
.	O	PUNCT	O


The	O	DET	O
hydrophobicity	O	NOUN	B
plot	O	NOUN	B
of	O	ADP	O
NHE	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
is	O	AUX	O
very	O	ADV	O
similar	O	ADJ	O
to	O	PART	O
that	O	DET	O
of	O	ADP	O
NHE	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
and	O	CCONJ	O
NHE	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
.	O	PUNCT	O


We	O	PRON	O
have	O	AUX	O
constructed	O	VERB	O
,	O	PUNCT	O
using	O	VERB	O
synthetic	O	ADJ	B
DNA	O	NOUN	I
oligonucleotides	O	NOUN	I
,	O	PUNCT	O
a	O	DET	O
U14	B-GENE	NOUN	B
snRNA	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
which	O	DET	O
has	O	AUX	O
been	O	AUX	O
positioned	O	ADJ	O
behind	O	ADP	O
a	O	DET	O
T7	B-GENE	NOUN	B
RNA	I-GENE	NOUN	I
polymerase	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
site	I-GENE	NOUN	I
and	O	CCONJ	O
then	O	ADV	O
inserted	O	VERB	B
into	O	ADP	O
a	O	DET	O
plasmid	O	NOUN	B
.	O	PUNCT	O


In	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
tobacco	B-GENE	X	B
GS	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
is	O	AUX	O
composed	O	VERB	O
of	O	ADP	O
subunits	O	NOUN	B
of	O	ADP	O
identical	O	ADJ	B
size	O	NOUN	B
in	O	ADP	O
all	O	DET	O
organs	O	NOUN	B
examined	O	VERB	B
.	O	PUNCT	O


Surprisingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
full	O	ADJ	B
-	O	PUNCT	O
deletion	O	NOUN	B
mutant	O	NOUN	O
showed	O	VERB	O
a	O	DET	O
strong	O	ADJ	O
block	O	NOUN	B
in	O	ADP	O
virus	O	NOUN	B
release	O	NOUN	B
,	O	PUNCT	O
suggesting	O	VERB	O
that	O	SCONJ	O
NC	B-GENE	PROPN	B
is	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
virus	O	NOUN	B
assembly	O	NOUN	B
.	O	PUNCT	O


Here	O	ADV	O
we	O	PRON	O
demonstrate	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
protein	O	NOUN	B
product	O	NOUN	I
of	O	ADP	O
the	O	DET	O
ref	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
gene	I-GENE	NOUN	B
stimulates	O	VERB	B
the	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
activity	O	NOUN	I
of	O	ADP	O
Fos	B-GENE	NOUN	B
-	O	PUNCT	O
Jun	B-GENE	NOUN	B
heterodimers	O	NOUN	I
,	O	PUNCT	O
Jun	B-GENE	NOUN	B
-	O	PUNCT	O
Jun	B-GENE	NOUN	B
homodimers	O	NOUN	I
and	O	CCONJ	O
Hela	O	NOUN	B
cell	O	NOUN	I
AP	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
proteins	I-GENE	NOUN	I
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
that	O	DET	O
of	O	ADP	O
several	O	ADJ	O
other	O	ADJ	O
transcription	O	NOUN	B
factors	O	NOUN	I
including	O	VERB	O
NF	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	I
,	O	PUNCT	O
Myb	B-GENE	NOUN	B
and	O	CCONJ	O
members	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ATF	B-GENE	NOUN	B
/	O	SYM	O
CREB	B-GENE	NOUN	B
family	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
ARG	B-GENE	NOUN	B
SH2	B-GENE	NOUN	B
domain	I-GENE	NOUN	I
exhibited	O	VERB	O
relatively	O	ADV	O
weak	O	ADJ	B
affinity	O	NOUN	B
for	O	ADP	O
BCR	B-GENE	NOUN	B
and	O	CCONJ	O
was	O	AUX	O
determined	O	VERB	O
to	O	PART	O
bind	O	VERB	B
about	O	ADV	O
10	O	NUM	O
-	O	PUNCT	O
fold	O	NOUN	B
less	O	ADV	O
strongly	O	ADV	O
than	O	ADP	O
the	O	DET	O
ABL	B-GENE	NOUN	B
SH2	B-GENE	NOUN	B
domain	I-GENE	NOUN	I
.	O	PUNCT	O


Through	O	ADP	O
Southern	O	NOUN	B
blot	O	NOUN	I
analyses	O	NOUN	I
of	O	ADP	O
DNA	O	NOUN	B
from	O	ADP	O
backcross	O	NOUN	B
and	O	CCONJ	O
cogenic	O	ADJ	B
mice	O	NOUN	I
,	O	PUNCT	O
recombinant	O	ADJ	B
inbred	O	ADJ	I
strains	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
somatic	O	ADJ	B
cell	O	NOUN	I
hybrids	O	NOUN	I
,	O	PUNCT	O
the	O	DET	O
genetic	O	ADJ	B
loci	O	NOUN	I
that	O	PRON	O
produce	O	VERB	O
the	O	DET	O
cyclin	B-GENE	NOUN	B
B1	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
related	I-GENE	VERB	B
sequences	I-GENE	NOUN	B
(	O	PUNCT	O
designated	O	VERB	O
loci	B-GENE	NOUN	B
Cycb1	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
rs1	I-GENE	PROPN	B
to	O	PART	O
Cycb1	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
rs9	I-GENE	NUM	B
)	O	PUNCT	O
were	O	AUX	O
mapped	O	VERB	B
on	O	ADP	O
mouse	O	NOUN	B
chromosomes	O	NOUN	I
5	O	NUM	I
,	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
17	O	NUM	O
,	O	PUNCT	O
4	O	NUM	O
,	O	PUNCT	O
14	O	NUM	O
,	O	PUNCT	O
13	O	NUM	O
,	O	PUNCT	O
7	O	NUM	O
,	O	PUNCT	O
X	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
8	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
treatment	O	NOUN	B
group	O	NOUN	I
also	O	ADV	O
showed	O	VERB	O
in	O	X	B
vivo	O	X	I
T	O	NOUN	B
-	O	PUNCT	O
cell	O	NOUN	B
activation	O	NOUN	B
with	O	ADP	O
an	O	DET	O
initial	O	ADJ	O
lymphopenia	O	NOUN	B
followed	O	VERB	O
by	O	ADP	O
a	O	DET	O
rebound	O	ADJ	O
lymphocytosis	O	NOUN	B
and	O	CCONJ	O
upregulation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
subset	O	NOUN	O
markers	O	NOUN	B
CD25	B-GENE	NOUN	B
(	O	PUNCT	O
interleukin	B-GENE	NOUN	B
2	I-GENE	NUM	I
receptor	I-GENE	NOUN	I
)	O	PUNCT	O
and	O	CCONJ	O
CD45RO	B-GENE	NOUN	B
(	O	PUNCT	O
T	O	NOUN	B
-	O	PUNCT	O
memory	O	NOUN	B
cells	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


Urease	B-GENE	NOUN	B
activity	O	NOUN	I
,	O	PUNCT	O
judged	O	VERB	O
as	O	ADP	O
the	O	DET	O
amount	O	NOUN	B
of	O	ADP	O
ammonia	O	NOUN	B
production	O	NOUN	I
from	O	ADP	O
urea	O	NOUN	B
,	O	PUNCT	O
could	O	AUX	O
be	O	AUX	O
measured	O	VERB	B
at	O	ADP	O
25	O	NUM	O
ng	O	NOUN	O
per	O	ADP	B
tube	O	NOUN	I
(	O	PUNCT	O
S	O	PROPN	B
/	O	SYM	O
N	O	NOUN	B
=	O	ADJ	O
1	O	NUM	O
.	O	PUNCT	O
5	O	NUM	O
)	O	PUNCT	O
with	O	ADP	O
Jack	B-GENE	PROPN	B
bean	I-GENE	NOUN	I
meal	I-GENE	NOUN	B
urease	I-GENE	NOUN	B
.	O	PUNCT	O


Our	O	PRON	O
experiments	O	NOUN	B
suggest	O	VERB	O
that	O	SCONJ	O
the	O	DET	O
SCL	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
can	O	AUX	O
be	O	AUX	O
a	O	DET	O
target	O	NOUN	B
for	O	ADP	O
the	O	DET	O
erythroid	B-GENE	ADJ	B
transcription	I-GENE	NOUN	I
factor	I-GENE	NOUN	I
GATA	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
and	O	CCONJ	O
that	O	SCONJ	O
the	O	DET	O
SCL	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
product	I-GENE	NOUN	O
serves	O	VERB	O
as	O	ADP	O
a	O	DET	O
positive	O	ADJ	B
regulator	O	NOUN	B
of	O	ADP	O
erythroid	O	ADJ	B
differentiation	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
temperature	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
cold	O	ADJ	B
-	O	PUNCT	O
sensitive	O	ADJ	B
strains	O	NOUN	B
were	O	AUX	O
used	O	VERB	O
to	O	PART	O
prepare	O	VERB	O
extracts	O	NOUN	B
deficient	O	ADJ	B
in	O	ADP	O
BRF1	B-GENE	NOUN	B
activity	O	NOUN	B
and	O	CCONJ	O
were	O	AUX	O
tested	O	VERB	B
for	O	ADP	O
transcriptional	O	ADJ	B
activity	O	NOUN	I
by	O	ADP	O
RNA	B-GENE	NOUN	B
polymerases	I-GENE	NOUN	I
I	I-GENE	NOUN	I
,	I-GENE	PUNCT	O
II	I-GENE	NUM	B
,	I-GENE	PUNCT	O
and	I-GENE	CCONJ	O
III	I-GENE	NUM	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


Cleavage	O	NOUN	B
by	O	ADP	O
the	O	DET	O
intron	O	NOUN	B
-	O	PUNCT	O
encoded	O	VERB	B
enzyme	O	NOUN	B
(	O	PUNCT	O
I	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
CreI	I-GENE	NOUN	B
)	O	PUNCT	O
occurs	O	VERB	O
5	O	NUM	O
bp	O	NOUN	O
and	O	CCONJ	O
1	O	NUM	O
bp	O	NOUN	O
3	O	NUM	O
'	O	PUNCT	O
to	O	PART	O
the	O	DET	O
intron	O	NOUN	B
insertion	O	NOUN	O
site	O	NOUN	O
(	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
3	O	NUM	O
'	O	PART	O
-	O	PUNCT	O
exon	O	NOUN	B
)	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
top	O	NOUN	B
(	O	PUNCT	B
/	O	SYM	O
)	O	PUNCT	B
and	O	CCONJ	O
bottom	O	NOUN	B
(	O	PUNCT	O
,	O	PUNCT	O
)	O	PUNCT	O
strands	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
,	O	PUNCT	O
resulting	O	VERB	O
in	O	ADP	O
4	O	NUM	O
-	O	PUNCT	O
nt	O	NOUN	B
single	O	ADJ	B
-	O	PUNCT	O
stranded	O	VERB	B
overhangs	O	NOUN	B
with	O	ADP	O
3	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
OH	O	NOUN	B
termini	O	NOUN	B
.	O	PUNCT	O


Surprisingly	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
Xenopus	B-GENE	NOUN	B
U7	I-GENE	NOUN	I
gene	I-GENE	NOUN	I
contains	O	VERB	O
two	O	NUM	O
adjacent	O	ADJ	B
octamer	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
motifs	O	NOUN	B
located	O	ADJ	O
only	O	ADV	O
12	O	NUM	O
and	O	CCONJ	O
24	O	NUM	O
bp	O	NOUN	O
upstream	O	ADJ	O
from	O	ADP	O
the	O	DET	O
PSE	B-GENE	NOUN	B
,	O	PUNCT	O
instead	O	ADV	O
of	O	ADP	O
the	O	DET	O
usual	O	ADJ	O
location	O	NOUN	B
around	O	ADP	O
150	O	NUM	O
-	O	PUNCT	O
200	O	NUM	O
bp	O	NOUN	O
upstream	O	ADJ	B
.	O	PUNCT	O


In	O	ADP	O
humans	O	NOUN	B
,	O	PUNCT	O
four	O	NUM	O
AMP	B-GENE	NOUN	B
deaminase	I-GENE	NOUN	B
variants	I-GENE	NOUN	B
,	O	PUNCT	O
termed	O	VERB	O
M	B-GENE	NOUN	B
(	O	PUNCT	O
muscle	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
L	B-GENE	NOUN	B
(	O	PUNCT	O
liver	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
E1	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
E2	B-GENE	NOUN	B
(	O	PUNCT	O
erythrocyte	O	NOUN	B
)	O	PUNCT	O
can	O	AUX	O
be	O	AUX	O
distinguished	O	VERB	O
by	O	ADP	O
a	O	DET	O
variety	O	NOUN	O
of	O	ADP	O
biochemical	O	ADJ	B
and	O	CCONJ	O
immunological	O	ADJ	B
criteria	O	NOUN	I
.	O	PUNCT	O


Behind	O	VERB	B
the	O	DET	O
ATPase	B-GENE	NOUN	B
cluster	I-GENE	NOUN	B
,	O	PUNCT	O
two	O	NUM	O
open	O	ADJ	O
reading	O	NOUN	O
frames	O	NOUN	O
were	O	AUX	O
detected	O	VERB	B
that	O	PRON	O
are	O	AUX	O
not	O	PART	O
homologous	O	ADJ	O
to	O	PART	O
any	O	DET	O
known	O	ADJ	O
chloroplast	O	NOUN	B
gene	O	NOUN	I
.	O	PUNCT	O


Using	O	VERB	O
either	O	CCONJ	O
a	O	DET	O
p50	B-GENE	NOUN	B
-	O	PUNCT	O
or	O	CCONJ	O
p65	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
selected	I-GENE	VERB	B
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	I
motif	I-GENE	NOUN	I
,	O	PUNCT	O
which	O	DET	O
displayed	O	VERB	O
differential	O	ADJ	O
binding	O	NOUN	O
with	O	ADP	O
respect	O	NOUN	O
to	O	PART	O
the	O	DET	O
other	O	ADJ	O
protein	O	NOUN	B
,	O	PUNCT	O
little	O	ADJ	O
to	O	PART	O
no	O	DET	O
binding	O	NOUN	B
was	O	AUX	O
observed	O	VERB	O
with	O	ADP	O
the	O	DET	O
heterodimeric	B-GENE	ADJ	B
NF	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
kappa	I-GENE	NOUN	B
B	I-GENE	NOUN	I
complex	I-GENE	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
cosmid	O	NOUN	B
clone	O	NOUN	B
containing	O	VERB	O
the	O	DET	O
entire	O	ADJ	O
mouse	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
1	I-GENE	NUM	I
(	I-GENE	PUNCT	O
I	I-GENE	NOUN	O
)	I-GENE	PUNCT	O
gene	I-GENE	NOUN	O
,	O	PUNCT	O
including	O	VERB	O
3	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
kb	O	NOUN	O
of	O	ADP	O
5	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
and	O	CCONJ	O
4	O	NUM	O
kb	O	NOUN	O
of	O	ADP	O
3	O	NUM	O
'	O	PUNCT	O
-	O	PUNCT	O
flanking	O	ADJ	B
DNA	O	NOUN	B
,	O	PUNCT	O
was	O	AUX	O
expressed	O	VERB	B
at	O	ADP	O
reduced	O	VERB	B
levels	O	NOUN	B
in	O	ADP	O
fibroblasts	O	NOUN	B
overexpressing	O	VERB	B
oncogenic	B-GENE	ADJ	B
ras	I-GENE	NOUN	B
.	O	PUNCT	O


By	O	ADP	O
screening	O	VERB	B
a	O	DET	O
Y1	O	NOUN	B
cell	O	NOUN	I
cDNA	O	NOUN	O
library	O	NOUN	O
with	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
H	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2RIIBP	I-GENE	NUM	B
nuclear	I-GENE	ADJ	B
hormone	I-GENE	NOUN	I
receptor	I-GENE	NOUN	I
cDNA	I-GENE	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
isolated	O	VERB	B
a	O	DET	O
cDNA	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
selectively	O	ADV	O
expressed	O	VERB	B
in	O	ADP	O
steroidogenic	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
using	O	VERB	O
lambda	O	NOUN	B
gt11	O	NOUN	I
expression	O	NOUN	B
cloning	O	VERB	I
with	O	ADP	O
oligonucleotides	O	NOUN	B
corresponding	O	VERB	O
to	O	PART	O
the	O	DET	O
human	O	ADJ	B
immunodeficiency	O	NOUN	I
virus	O	NOUN	I
1	O	NUM	I
TATA	O	NOUN	B
element	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
report	O	VERB	O
the	O	DET	O
identification	O	NOUN	B
of	O	ADP	O
a	O	DET	O
cellular	O	ADJ	B
protein	O	NOUN	I
with	O	ADP	O
a	O	DET	O
calculated	O	VERB	O
molecular	O	ADJ	B
mass	O	NOUN	I
of	O	ADP	O
123	O	NUM	O
kDa	O	NOUN	O
that	O	PRON	O
we	O	PRON	O
designate	O	VERB	O
TATA	B-GENE	NOUN	B
element	I-GENE	NOUN	O
modulatory	I-GENE	ADJ	B
factor	I-GENE	NOUN	I
(	O	PUNCT	O
TMF	B-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Blood	O	NOUN	B
levels	O	NOUN	I
of	O	ADP	O
melatonin	O	NOUN	B
,	O	PUNCT	O
serotonin	O	NOUN	B
,	O	PUNCT	O
cortisol	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
prolactin	B-GENE	NOUN	B
in	O	ADP	O
relation	O	NOUN	O
to	O	PART	O
the	O	DET	O
circadian	O	ADJ	B
rhythm	O	NOUN	I
of	O	ADP	O
platelet	O	NOUN	B
serotonin	O	NOUN	I
uptake	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
5	O	NUM	O
ng	O	NOUN	O
/	O	PUNCT	O
mL	O	NOUN	O
as	O	ADP	O
the	O	DET	O
cutoff	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
sensitivity	O	NOUN	B
of	O	ADP	O
CEA	B-GENE	NOUN	B
was	O	AUX	O
68	O	NUM	O
%	O	NOUN	O
.	O	PUNCT	O


Of	O	ADP	O
the	O	DET	O
serum	B-GENE	NOUN	B
neutralizing	I-GENE	NOUN	I
(	I-GENE	PUNCT	O
SN	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
antibody	I-GENE	NOUN	B
negative	O	ADJ	O
calves	O	NOUN	B
89	O	NUM	O
.	O	PUNCT	O
7	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
26	O	NUM	O
/	O	SYM	O
29	O	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
92	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
%	O	NOUN	O
(	O	PUNCT	O
90	O	NUM	O
/	O	SYM	O
97	O	NUM	O
)	O	PUNCT	O
developed	O	VERB	O
SN	B-GENE	NOUN	B
antibody	I-GENE	NOUN	I
1	O	NUM	I
month	O	NOUN	B
after	O	ADP	O
intranasal	O	ADJ	B
and	O	CCONJ	O
intramuscular	O	ADJ	B
vaccination	O	NOUN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


A	O	DET	O
controlled	O	ADJ	B
trial	O	NOUN	I
of	O	ADP	O
recombinant	B-GENE	ADJ	B
human	I-GENE	ADJ	O
granulocyte	I-GENE	NOUN	O
-	I-GENE	PUNCT	O
macrophage	I-GENE	NOUN	B
colony	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
stimulating	I-GENE	VERB	B
factor	I-GENE	NOUN	B
after	O	ADP	O
total	O	ADJ	B
body	O	NOUN	I
irradiation	O	NOUN	I
,	O	PUNCT	O
high	O	ADJ	B
-	O	PUNCT	O
dose	O	NOUN	B
chemotherapy	O	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
autologous	O	ADJ	B
bone	O	NOUN	I
marrow	O	NOUN	I
transplantation	O	NOUN	I
for	O	ADP	O
acute	O	ADJ	B
lymphoblastic	O	ADJ	I
leukemia	O	NOUN	I
or	O	CCONJ	O
malignant	O	ADJ	B
lymphoma	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
IgG	B-GENE	NOUN	B
subclass	O	NOUN	O
profile	O	NOUN	O
of	O	ADP	O
untreated	O	ADJ	B
coeliac	O	ADJ	B
disease	O	NOUN	I
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
the	O	DET	O
same	O	ADJ	O
as	O	ADP	O
in	O	ADP	O
healthy	O	ADJ	B
controls	O	NOUN	I
(	O	PUNCT	O
IgG1	B-GENE	NOUN	B
approximately	O	ADV	B
IgG2	B-GENE	NOUN	B
>	O	X	O
IgG3	B-GENE	NOUN	B
>	O	X	O
IgG4	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
with	O	ADP	O
only	O	ADV	O
the	O	DET	O
magnitude	O	NOUN	B
of	O	ADP	O
the	O	DET	O
individual	O	ADJ	B
subclass	O	NOUN	O
responses	O	NOUN	O
being	O	AUX	O
increased	O	VERB	B
in	O	ADP	O
coeliac	O	ADJ	B
patients	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
distinguishing	O	ADJ	O
features	O	NOUN	B
involved	O	VERB	O
eight	O	NUM	O
amino	O	NOUN	B
acid	O	NOUN	I
changes	O	NOUN	I
,	O	PUNCT	O
including	O	VERB	O
a	O	DET	O
single	O	ADJ	O
lysine	O	NOUN	O
deletion	O	NOUN	O
relative	O	ADJ	O
to	O	PART	O
a	O	DET	O
primate	O	ADJ	B
consensus	O	NOUN	B
sequence	O	NOUN	I
in	O	ADP	O
the	O	DET	O
first	O	ADJ	O
complementary	O	ADJ	B
-	O	PUNCT	O
determing	O	VERB	B
region	O	NOUN	I
of	O	ADP	O
V1J1	B-GENE	NOUN	B
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
basis	O	NOUN	O
of	O	ADP	O
these	O	DET	O
unique	O	ADJ	B
properties	O	NOUN	B
,	O	PUNCT	O
the	O	DET	O
newly	O	ADV	O
characterized	O	VERB	B
hemagglutinin	B-GENE	NOUN	B
has	O	AUX	O
been	O	AUX	O
termed	O	VERB	O
Limulus	B-GENE	ADJ	B
18K	I-GENE	NOUN	I
agglutination	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
aggregation	I-GENE	NOUN	B
factor	I-GENE	NOUN	I
(	O	PUNCT	O
18K	B-GENE	NUM	B
-	I-GENE	PUNCT	O
LAF	I-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
shift	O	NOUN	B
to	O	PART	O
the	O	DET	O
nonpermissive	O	ADJ	B
temperature	O	NOUN	B
is	O	AUX	O
accompanied	O	VERB	O
by	O	ADP	O
the	O	DET	O
loss	O	NOUN	B
of	O	ADP	O
guanyl	O	NOUN	B
nucleotide	O	NOUN	I
-	O	PUNCT	O
dependent	O	ADJ	B
activity	O	NOUN	B
of	O	ADP	O
adenylylcyclase	B-GENE	NOUN	B
in	O	X	B
vitro	O	X	I
.	O	PUNCT	O


It	O	PRON	O
corresponds	O	VERB	O
to	O	ADP	O
the	O	DET	O
complete	O	ADJ	O
mitochondrial	O	ADJ	B
presequence	O	NOUN	B
and	O	CCONJ	O
the	O	DET	O
lipoyl	O	NOUN	B
-	O	PUNCT	O
bearing	O	VERB	B
domain	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
encoded	O	VERB	B
by	O	ADP	O
exons	O	NOUN	B
I	O	NUM	I
through	O	ADP	O
IV	O	NUM	B
of	O	ADP	O
the	O	DET	O
functional	O	ADJ	B
E2	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


A	O	DET	O
mutant	O	ADJ	B
form	O	NOUN	O
of	O	ADP	O
Vps1p	B-GENE	NOUN	B
lacking	O	VERB	B
the	O	DET	O
entire	O	ADJ	O
GTP	O	NOUN	B
-	O	PUNCT	O
binding	O	VERB	B
domain	O	NOUN	O
interfered	O	VERB	B
with	O	ADP	O
vacuolar	O	ADJ	B
protein	O	NOUN	I
sorting	O	NOUN	I
in	O	ADP	O
wild	O	ADJ	B
-	O	PUNCT	O
type	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


Nucleotide	O	NOUN	B
sequence	O	NOUN	I
and	O	CCONJ	O
transcriptional	O	ADJ	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
polyhedrin	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
of	O	ADP	O
Spodoptera	O	NOUN	B
exigua	O	X	I
nuclear	O	ADJ	B
polyhedrosis	O	NOUN	I
virus	O	NOUN	I
.	O	PUNCT	O


Interferon	B-GENE	NOUN	B
type	I-GENE	NOUN	I
I	I-GENE	NUM	I
in	O	ADP	O
protective	O	ADJ	B
body	O	NOUN	I
reactions	O	NOUN	I
in	O	ADP	O
an	O	DET	O
experimental	O	ADJ	B
Klebsiella	O	X	B
infection	O	NOUN	I


No	O	DET	O
other	O	ADJ	O
changes	O	NOUN	B
in	O	ADP	O
hematopoietic	O	ADJ	B
differentiation	O	NOUN	I
status	O	NOUN	I
were	O	AUX	O
observed	O	VERB	O
in	O	ADP	O
association	O	NOUN	B
with	O	ADP	O
Id	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
SCL	I-GENE	NOUN	B
expression	O	NOUN	B
.	O	PUNCT	O


These	O	DET	O
data	O	NOUN	B
indicate	O	VERB	O
that	O	SCONJ	O
RNK	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Met	I-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
is	O	AUX	O
a	O	DET	O
serine	B-GENE	NOUN	B
protease	I-GENE	NOUN	I
with	O	ADP	O
unique	O	ADJ	O
activity	O	NOUN	B
that	O	PRON	O
is	O	AUX	O
expressed	O	VERB	B
in	O	ADP	O
the	O	DET	O
granules	O	NOUN	B
of	O	ADP	O
large	O	ADJ	O
granular	O	ADJ	B
lymphocytes	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
describe	O	VERB	O
here	O	ADV	O
17	O	NUM	O
dominant	B-GENE	ADJ	B
GCN2	I-GENE	NOUN	B
mutations	I-GENE	NOUN	B
that	O	PRON	O
lead	O	VERB	O
to	O	PART	O
derepression	O	NOUN	B
of	O	ADP	O
GCN4	B-GENE	NOUN	B
expression	O	NOUN	B
in	O	ADP	O
the	O	DET	O
absence	O	NOUN	B
of	O	ADP	O
amino	O	NOUN	B
acid	O	NOUN	I
starvation	O	NOUN	I
.	O	PUNCT	O


In	O	ADP	O
addition	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
utility	O	NOUN	O
of	O	ADP	O
beta	B-GENE	NOUN	B
2	I-GENE	NUM	I
transferrin	I-GENE	NOUN	I
assay	O	NOUN	I
in	O	ADP	O
the	O	DET	O
diagnosis	O	NOUN	B
of	O	ADP	O
cerebrospinal	O	ADJ	B
fluid	O	ADJ	I
otorrhea	O	NOUN	O
is	O	AUX	O
presented	O	VERB	O
.	O	PUNCT	O


The	O	DET	O
structural	O	ADJ	B
genes	O	NOUN	I
encoding	O	VERB	B
glyceraldehyde	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
3	I-GENE	NUM	B
-	I-GENE	PUNCT	O
phosphate	I-GENE	NOUN	B
dehydrogenase	I-GENE	NOUN	I
(	O	PUNCT	O
GAPDH	B-GENE	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
3	B-GENE	NUM	O
-	I-GENE	PUNCT	O
phosphoglycerate	I-GENE	NOUN	B
kinase	I-GENE	NOUN	I
(	O	PUNCT	O
PGK	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
N	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
part	O	NOUN	O
of	O	ADP	O
triosephosphate	B-GENE	ADJ	B
isomerase	I-GENE	NOUN	I
(	O	PUNCT	O
TIM	B-GENE	NOUN	B
)	O	PUNCT	O
from	O	ADP	O
mesophilic	O	ADJ	B
Bacillus	O	X	B
megaterium	O	X	I
DSM319	O	X	I
have	O	AUX	O
been	O	AUX	O
cloned	O	VERB	B
as	O	ADP	O
a	O	DET	O
gene	O	NOUN	B
cluster	O	NOUN	I
(	O	PUNCT	O
gap	B-GENE	NOUN	B
operon	I-GENE	NOUN	I
)	O	PUNCT	O
by	O	ADP	O
complementation	O	NOUN	B
of	O	ADP	O
an	O	DET	O
Escherichia	O	X	B
coli	O	X	I
gap	B-GENE	NOUN	B
amber	I-GENE	NOUN	B
mutant	I-GENE	NOUN	I
.	O	PUNCT	O


Mono	O	NOUN	B
-	O	PUNCT	O
ADP	O	PROPN	B
-	O	PUNCT	O
ribosylation	O	NOUN	B
is	O	AUX	O
a	O	DET	O
reversible	O	ADJ	O
modification	O	NOUN	B
of	O	ADP	O
proteins	O	NOUN	B
,	O	PUNCT	O
with	O	ADP	O
NAD	O	NOUN	B
:	O	PUNCT	O
arginine	B-GENE	NOUN	B
ADP	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
ribosyltransferases	I-GENE	NOUN	B
(	O	PUNCT	O
EC	B-GENE	NOUN	B
2	I-GENE	NUM	O
.	I-GENE	PUNCT	O
4	I-GENE	NUM	O
.	I-GENE	PUNCT	O
2	I-GENE	NUM	O
.	I-GENE	PUNCT	O
31	I-GENE	NUM	O
)	O	PUNCT	O
and	O	CCONJ	O
ADP	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
ribosylarginine	I-GENE	NOUN	B
hydrolases	I-GENE	NOUN	B
(	O	PUNCT	O
EC	B-GENE	NOUN	B
3	I-GENE	NUM	I
.	I-GENE	PUNCT	O
2	I-GENE	NUM	O
.	I-GENE	PUNCT	O
2	I-GENE	NUM	O
.	I-GENE	PUNCT	O
19	I-GENE	NUM	O
)	O	PUNCT	O
catalyzing	O	VERB	O
the	O	DET	O
opposing	O	ADJ	O
reactions	O	NOUN	O
in	O	ADP	O
an	O	DET	O
ADP	O	NOUN	B
-	O	PUNCT	O
ribosylation	O	NOUN	B
cycle	O	NOUN	O
.	O	PUNCT	O


For	O	ADP	O
this	O	DET	O
reason	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
particle	O	NOUN	B
forming	O	NOUN	I
capacity	O	NOUN	B
of	O	ADP	O
derivatives	O	NOUN	O
of	O	ADP	O
the	O	DET	O
HIV	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
group	I-GENE	NOUN	B
specific	I-GENE	ADJ	O
core	I-GENE	NOUN	O
antigen	I-GENE	NOUN	O
p55	I-GENE	NOUN	B
gag	I-GENE	NOUN	I
was	O	AUX	O
assayed	O	VERB	B
and	O	CCONJ	O
compared	O	VERB	B
dependent	O	ADJ	B
on	O	ADP	O
various	O	ADJ	O
expression	O	NOUN	B
systems	O	NOUN	I
:	O	PUNCT	O
recombinant	O	ADJ	B
bacteria	O	NOUN	I
,	O	PUNCT	O
vaccinia	O	NOUN	B
-	O	PUNCT	O
and	O	CCONJ	O
baculoviruses	O	NOUN	B
were	O	AUX	O
established	O	VERB	O
encoding	O	VERB	B
the	O	DET	O
entire	O	ADJ	O
core	B-GENE	NOUN	O
protein	I-GENE	NOUN	O
p55	I-GENE	NOUN	O
either	O	CCONJ	O
in	O	ADP	O
its	O	PRON	O
authentic	O	ADJ	B
sequence	O	NOUN	B
or	O	CCONJ	O
lacking	O	VERB	B
the	O	DET	O
myristylation	O	NOUN	B
consensus	O	NOUN	O
signal	O	NOUN	O
.	O	PUNCT	O


Removal	O	NOUN	B
of	O	ADP	O
beta	B-GENE	NOUN	B
2	I-GENE	NUM	I
-	I-GENE	PUNCT	O
microglobulin	I-GENE	NOUN	B
by	O	ADP	O
hemodialysis	O	NOUN	B
and	O	CCONJ	O
hemofiltration	O	NOUN	B
:	O	PUNCT	O
a	O	DET	O
four	O	NUM	O
year	O	NOUN	B
follow	O	VERB	B
up	O	ADP	I
.	O	PUNCT	O


Truncated	B-GENE	VERB	B
ICSBP	I-GENE	NOUN	B
lacking	O	VERB	O
the	O	DET	O
first	O	ADJ	O
33	O	NUM	O
amino	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
amino	O	NOUN	B
acids	O	NOUN	I
fails	O	VERB	O
to	O	PART	O
bind	O	VERB	B
to	O	PART	O
the	O	DET	O
ICS	B-GENE	PROPN	B
,	O	PUNCT	O
indicating	O	VERB	O
that	O	SCONJ	O
at	O	ADP	O
least	O	ADJ	O
part	O	NOUN	O
of	O	ADP	O
the	O	DET	O
DNA	O	NOUN	B
binding	O	NOUN	I
domain	O	NOUN	I
is	O	AUX	O
located	O	ADJ	O
within	O	ADP	O
the	O	DET	O
well	O	ADV	O
conserved	O	VERB	O
amino	O	NOUN	B
terminus	O	NOUN	I
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
ICSBP	B-GENE	NOUN	B
may	O	AUX	O
be	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
maintaining	O	VERB	O
submaximal	O	ADJ	B
transcriptional	O	ADJ	B
activity	O	NOUN	I
of	O	ADP	O
IFN	B-GENE	NOUN	B
-	O	PUNCT	O
inducible	O	ADJ	B
genes	O	NOUN	B
in	O	ADP	O
hematopoietic	O	ADJ	B
cells	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
coiled	B-GENE	VERB	B
-	I-GENE	PUNCT	O
coil	I-GENE	NOUN	B
related	I-GENE	ADJ	O
protein	I-GENE	NOUN	B
specific	O	ADJ	O
for	O	ADP	O
synapsed	O	VERB	B
regions	O	NOUN	I
of	O	ADP	O
meiotic	O	ADJ	B
prophase	O	NOUN	I
chromosomes	O	NOUN	O
.	O	PUNCT	O


Interestingly	O	ADV	O
,	O	PUNCT	O
a	O	DET	O
portion	O	NOUN	B
of	O	ADP	O
the	O	DET	O
tail	O	NOUN	B
domain	O	NOUN	I
(	O	PUNCT	O
aa	O	NOUN	B
,	O	PUNCT	O
1	O	NUM	O
,	O	PUNCT	O
094	O	NUM	O
-	O	SYM	O
1	O	NUM	O
,	O	PUNCT	O
830	O	NUM	O
)	O	PUNCT	O
shares	O	VERB	O
58	O	NUM	O
%	O	NOUN	O
amino	O	NOUN	B
acid	O	NOUN	I
sequence	O	NOUN	I
identity	O	NOUN	B
with	O	ADP	O
a	O	DET	O
723	O	NUM	O
-	O	PUNCT	O
aa	O	NOUN	B
protein	O	NOUN	I
from	O	ADP	O
mouse	O	NOUN	B
brain	O	NOUN	B
reported	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
glutamic	B-GENE	ADJ	B
acid	I-GENE	NOUN	I
decarboxylase	I-GENE	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
in	O	ADP	O
the	O	DET	O
subgroup	O	NOUN	B
with	O	ADP	O
normal	O	ADJ	O
Ht	O	NOUN	O
(	O	PUNCT	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
45	O	NUM	O
l	O	X	O
/	O	SYM	O
l	O	NOUN	O
;	O	PUNCT	O
n	O	NOUN	O
=	O	ADJ	O
201	O	NUM	O
)	O	PUNCT	O
there	O	PRON	O
was	O	AUX	O
a	O	DET	O
significant	O	ADJ	O
reduction	O	NOUN	B
(	O	PUNCT	O
p	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
05	O	NUM	O
)	O	PUNCT	O
of	O	ADP	O
the	O	DET	O
mortality	O	NOUN	B
after	O	ADP	O
3	O	NUM	O
months	O	NOUN	B
(	O	PUNCT	O
27	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
16	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
and	O	CCONJ	O
an	O	DET	O
increase	O	NOUN	B
of	O	ADP	O
independence	O	NOUN	B
at	O	ADP	O
home	O	NOUN	B
(	O	PUNCT	O
35	O	NUM	O
%	O	NOUN	O
and	O	CCONJ	O
48	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
due	O	ADP	O
to	O	PART	O
a	O	DET	O
reduction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
viscosity	O	NOUN	B
by	O	ADP	O
means	O	NOUN	O
of	O	ADP	O
haemodilution	O	NOUN	B
with	O	ADP	O
albumin	B-GENE	NOUN	B
(	O	PUNCT	O
a	O	DET	O
specific	O	ADJ	O
viscosity	O	NOUN	B
effect	O	NOUN	O
in	O	ADP	O
the	O	DET	O
normovolaemic	O	ADJ	B
group	O	NOUN	I
)	O	PUNCT	O
.	O	PUNCT	O


RESULTS	O	NOUN	B
:	O	PUNCT	O
In	O	ADP	O
the	O	DET	O
AGA	O	NOUN	B
group	O	NOUN	B
,	O	PUNCT	O
both	O	CCONJ	O
fetal	O	ADJ	B
and	O	CCONJ	O
maternal	O	ADJ	B
serum	O	NOUN	O
prolactin	B-GENE	NOUN	B
concentration	O	NOUN	I
increased	O	VERB	B
significantly	O	ADV	B
with	O	ADP	I
gestation	O	NOUN	B
(	O	PUNCT	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
001	O	NUM	O
and	O	CCONJ	O
P	O	NOUN	O
<	O	X	O
0	O	NUM	O
.	O	PUNCT	O
01	O	NUM	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
.	O	PUNCT	O


Therefore	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
molecular	O	ADJ	B
mechanisms	O	NOUN	I
of	O	ADP	O
the	O	DET	O
estrogen	O	NOUN	B
action	O	NOUN	I
that	O	PRON	O
govern	O	VERB	O
the	O	DET	O
lactoferrin	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
expression	O	NOUN	I
differ	O	VERB	O
between	O	ADP	O
mouse	O	NOUN	B
and	O	CCONJ	O
human	O	ADJ	B
.	O	PUNCT	O


Four	O	NUM	O
short	O	ADJ	B
nucleotide	O	NOUN	I
sequences	O	NOUN	I
(	O	PUNCT	O
boxes	O	NOUN	B
I	O	NUM	I
to	O	PART	I
IV	O	NUM	I
)	O	PUNCT	O
contribute	O	VERB	O
to	O	PART	O
the	O	DET	O
light	O	ADJ	O
responsiveness	O	NOUN	B
of	O	ADP	O
the	O	DET	O
parsley	B-GENE	NOUN	B
chalcone	I-GENE	NOUN	I
synthase	I-GENE	NOUN	I
promoter	I-GENE	NOUN	B
.	O	PUNCT	O


Exposure	O	NOUN	B
to	O	PART	I
hepatitis	O	NOUN	B
B	O	NOUN	I
virus	O	NOUN	I
in	O	ADP	O
the	O	DET	O
general	O	ADJ	B
population	O	NOUN	I
of	O	ADP	O
Hisayama	O	PROPN	B
,	O	PUNCT	O
Japan	O	PROPN	B
:	O	PUNCT	O
significance	O	NOUN	B
of	O	ADP	O
isolated	O	VERB	B
antibody	O	NOUN	O
to	O	PART	O
hepatitis	B-GENE	NOUN	B
B	I-GENE	NOUN	I
surface	I-GENE	NOUN	I
antigen	I-GENE	NOUN	I
in	O	ADP	O
general	O	ADJ	B
population	O	NOUN	I
.	O	PUNCT	O


On	O	ADP	O
the	O	DET	O
other	O	ADJ	O
hand	O	NOUN	B
,	O	PUNCT	O
neither	O	CCONJ	O
phosphate	O	NOUN	B
buffered	O	NOUN	O
saline	O	NOUN	B
injection	O	NOUN	I
into	O	ADP	O
the	O	DET	O
ES	O	NOUN	B
nor	O	CCONJ	O
primary	O	ADJ	O
KLH	B-GENE	NOUN	B
challenges	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ES	O	NOUN	B
were	O	AUX	O
capable	O	ADJ	O
of	O	ADP	O
elevating	O	VERB	B
the	O	DET	O
threshold	O	NOUN	B
level	O	NOUN	B
and	O	CCONJ	O
changing	O	VERB	B
the	O	DET	O
latency	O	NOUN	B
.	O	PUNCT	O


We	O	PRON	O
show	O	VERB	O
that	O	SCONJ	O
LexA	B-GENE	NOUN	B
-	O	PUNCT	O
GAL4	B-GENE	NOUN	B
and	O	CCONJ	O
LexA	B-GENE	NOUN	B
-	O	PUNCT	O
Bicoid	B-GENE	NOUN	B
fusion	O	NOUN	O
proteins	O	NOUN	O
are	O	AUX	O
both	O	CCONJ	O
dependent	O	ADJ	B
on	O	ADP	O
SNF2	B-GENE	NOUN	B
,	O	PUNCT	O
SNF5	B-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
SNF6	B-GENE	NOUN	B
for	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
target	O	NOUN	B
genes	O	NOUN	O
containing	O	VERB	O
one	O	NUM	O
or	O	CCONJ	O
multiple	O	ADJ	B
lexA	B-GENE	NOUN	B
operators	I-GENE	NOUN	I
.	O	PUNCT	O


NE	B-GENE	NOUN	B
and	O	CCONJ	O
PR3	B-GENE	NOUN	B
assist	O	NOUN	B
in	O	ADP	O
the	O	DET	O
destruction	O	NOUN	B
of	O	ADP	O
phagocytosed	O	VERB	B
microorganisms	O	NOUN	B
,	O	PUNCT	O
cleave	O	VERB	B
the	O	DET	O
important	O	ADJ	O
connective	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
tissue	I-GENE	NOUN	B
protein	I-GENE	NOUN	I
elastin	I-GENE	NOUN	B
,	O	PUNCT	O
and	O	CCONJ	O
generate	O	VERB	O
chemotactic	O	ADJ	B
activities	O	NOUN	I
by	O	ADP	O
forming	O	VERB	O
alpha	B-GENE	NOUN	O
1	I-GENE	NUM	O
-	I-GENE	PUNCT	O
proteinase	I-GENE	NOUN	B
inhibitor	I-GENE	NOUN	I
complexes	I-GENE	NOUN	B
and	O	CCONJ	O
elastin	B-GENE	NOUN	B
peptides	I-GENE	NOUN	I
.	O	PUNCT	O


By	O	ADP	O
contrast	O	NOUN	O
,	O	PUNCT	O
d	B-GENE	NOUN	O
(	I-GENE	PUNCT	O
T2AG3T	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
and	O	CCONJ	O
d	B-GENE	NOUN	O
(	I-GENE	PUNCT	O
T2G4T	I-GENE	NOUN	B
)	I-GENE	PUNCT	O
form	O	VERB	O
only	O	ADV	O
the	O	DET	O
G	O	NOUN	B
-	O	PUNCT	O
quadruplex	O	ADJ	B
monomer	O	NOUN	B
structures	O	NOUN	I
independent	O	ADJ	B
of	O	ADP	O
K	O	NOUN	B
cation	O	NOUN	I
concentration	O	NOUN	B
as	O	ADP	O
reported	O	VERB	O
previously	O	ADV	O
[	O	PUNCT	O
Sen	O	PROPN	B
,	O	PUNCT	O
D	O	PROPN	B
.	O	PUNCT	O
,	O	PUNCT	O
&	O	CCONJ	O
Gilbert	O	PROPN	B
,	O	PUNCT	O
W	O	PROPN	O
.	O	PUNCT	O


Interferon	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
alpha	I-GENE	NOUN	B
-	O	PUNCT	O
induced	O	VERB	B
gene	O	NOUN	B
expression	O	NOUN	I
:	O	PUNCT	O
evidence	O	NOUN	B
for	O	ADP	O
a	O	DET	O
selective	O	ADJ	O
effect	O	NOUN	B
of	O	ADP	O
ouabain	O	NOUN	B
on	O	ADP	O
activation	O	NOUN	B
of	O	ADP	O
the	O	DET	O
ISGF3	B-GENE	NOUN	B
transcription	I-GENE	NOUN	I
complex	I-GENE	NOUN	I
.	O	PUNCT	O


Among	O	ADP	O
the	O	DET	O
few	O	ADJ	O
proteins	O	NOUN	B
of	O	ADP	O
the	O	DET	O
eukaryotic	O	ADJ	B
nucleolus	O	NOUN	I
that	O	PRON	O
have	O	AUX	O
been	O	AUX	O
characterized	O	VERB	B
,	O	PUNCT	O
four	O	NUM	O
proteins	O	NOUN	B
,	O	PUNCT	O
nucleolin	B-GENE	NOUN	B
,	O	PUNCT	O
fibrillarin	B-GENE	NOUN	B
,	O	PUNCT	O
SSB1	B-GENE	NOUN	B
and	O	CCONJ	O
NSR1	B-GENE	NOUN	B
,	O	PUNCT	O
possess	O	VERB	O
a	O	DET	O
common	O	ADJ	O
structural	O	ADJ	B
motif	O	NOUN	O
,	O	PUNCT	O
the	O	DET	O
GAR	O	NOUN	B
domain	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
is	O	AUX	O
rich	O	ADJ	O
in	O	ADP	O
glycine	O	NOUN	B
and	O	CCONJ	O
arginine	O	NOUN	B
residues	O	NOUN	O
.	O	PUNCT	O


Switching	O	VERB	B
FDC	O	NOUN	B
-	O	PUNCT	O
P1	O	PROPN	B
/	O	SYM	O
MAC	O	NOUN	B
cells	O	NOUN	O
from	O	ADP	O
growth	O	NOUN	B
in	O	ADP	O
M	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
CSF	I-GENE	PROPN	B
to	O	ADP	O
GM	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
CSF	I-GENE	PROPN	B
caused	O	VERB	O
the	O	DET	O
selective	O	ADJ	O
degradation	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	O
-	I-GENE	PUNCT	O
fms	I-GENE	NOUN	B
mRNA	I-GENE	NOUN	B
within	O	ADP	O
6	O	NUM	O
h	O	NOUN	O
after	O	ADP	O
factor	O	NOUN	B
switching	O	NOUN	I
.	O	PUNCT	O


There	O	PRON	O
was	O	AUX	O
however	O	ADV	O
,	O	PUNCT	O
no	O	DET	B
significant	O	ADJ	I
difference	O	NOUN	O
in	O	ADP	O
the	O	DET	O
prevalence	O	NOUN	B
of	O	ADP	O
chronic	O	ADJ	B
respiratory	O	ADJ	I
symptoms	O	NOUN	I
between	O	ADP	O
animal	O	ADJ	B
food	O	NOUN	B
workers	O	NOUN	I
with	O	ADP	O
positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
skin	O	NOUN	O
tests	O	NOUN	O
to	O	PART	O
house	O	NOUN	B
dust	O	NOUN	I
or	O	CCONJ	O
to	O	PART	O
fish	O	VERB	B
flour	O	NOUN	I
or	O	CCONJ	O
among	O	ADP	O
those	O	DET	O
with	O	ADP	O
increased	O	VERB	B
or	O	CCONJ	O
normal	O	ADJ	B
IgE	B-GENE	NOUN	I
(	O	PUNCT	O
except	O	SCONJ	O
for	O	ADP	O
dyspnea	O	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


Using	O	VERB	O
bovine	B-GENE	NOUN	B
and	I-GENE	CCONJ	O
murine	I-GENE	ADJ	B
c	I-GENE	NOUN	O
-	I-GENE	PUNCT	O
myb	I-GENE	NOUN	B
clones	O	NOUN	I
,	O	PUNCT	O
no	O	DET	O
change	O	NOUN	O
in	O	ADP	O
the	O	DET	O
rate	O	NOUN	B
of	O	ADP	O
c	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
myb	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
transcription	O	NOUN	I
or	O	CCONJ	O
mRNA	O	NOUN	B
stability	O	NOUN	I
was	O	AUX	O
detected	O	VERB	B
during	O	ADP	O
the	O	DET	O
cell	O	NOUN	B
cycle	O	NOUN	I
.	O	PUNCT	O


Moreover	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
reconstitution	O	NOUN	B
of	O	ADP	O
eUSF	B-GENE	NOUN	B
and	O	CCONJ	O
TFIID	B-GENE	NOUN	B
-	O	PUNCT	O
depleted	O	VERB	B
transcription	O	NOUN	B
complexes	O	NOUN	I
with	O	ADP	O
purified	O	VERB	B
protein	O	NOUN	I
fractions	O	NOUN	O
demonstrate	O	VERB	O
that	O	SCONJ	O
not	O	PART	O
only	O	ADV	O
TFIID	B-GENE	NOUN	B
but	O	CCONJ	O
also	O	ADV	O
eUSF	B-GENE	NOUN	B
essentially	O	ADV	O
participates	O	VERB	B
in	O	ADP	O
complex	O	NOUN	B
formation	O	NOUN	B
even	O	ADV	O
on	O	ADP	O
H5	B-GENE	NOUN	B
promoter	I-GENE	NOUN	I
mutations	O	NOUN	I
lacking	O	VERB	O
the	O	DET	O
TATA	O	NOUN	B
-	O	PUNCT	O
box	O	NOUN	B
.	O	PUNCT	O


Nuclear	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
encoded	I-GENE	VERB	B
chloroplast	I-GENE	NOUN	B
ribosomal	I-GENE	ADJ	I
protein	I-GENE	NOUN	I
L12	I-GENE	NOUN	I
of	I-GENE	ADP	O
Nicotiana	I-GENE	NOUN	B
tabacum	I-GENE	NOUN	I
:	O	PUNCT	O
characterization	O	NOUN	B
of	O	ADP	O
mature	O	ADJ	B
protein	O	NOUN	B
and	O	CCONJ	O
isolation	O	NOUN	B
and	O	CCONJ	O
sequence	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
cDNA	O	NOUN	B
clones	O	NOUN	I
encoding	O	VERB	B
its	O	PRON	O
cytoplasmic	O	ADJ	B
precursor	O	NOUN	I
.	O	PUNCT	O


Characterization	O	NOUN	B
of	O	ADP	O
these	O	DET	O
R	O	NOUN	B
subunits	O	NOUN	I
by	O	ADP	O
their	O	PRON	O
8	O	NUM	O
-	O	PUNCT	O
azido	O	NOUN	B
-	O	PUNCT	O
cAMP	O	NOUN	B
photoaffinity	O	NOUN	B
labeling	O	NOUN	I
and	O	CCONJ	O
immunoreactivity	O	NOUN	B
,	O	PUNCT	O
as	O	ADV	O
well	O	ADV	O
as	O	ADP	O
by	O	ADP	O
a	O	DET	O
phosphorylation	O	NOUN	B
-	O	PUNCT	O
dependent	O	ADJ	B
mobility	O	NOUN	B
shift	O	NOUN	B
on	O	ADP	O
sodium	O	NOUN	B
dodecyl	O	NOUN	I
sulfate	O	NOUN	I
-	O	PUNCT	O
polyacrylamide	O	NOUN	B
gel	O	NOUN	I
electrophoresis	O	NOUN	I
(	O	PUNCT	O
SDS	O	NOUN	B
-	O	PUNCT	O
PAGE	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
indicated	O	VERB	O
subunit	O	NOUN	B
sizes	O	NOUN	O
of	O	ADP	O
RII	B-GENE	NOUN	B
beta	I-GENE	NOUN	B
(	O	PUNCT	O
53	O	NUM	O
kDa	O	NOUN	O
)	O	PUNCT	O
greater	O	ADJ	O
than	O	ADP	O
RII	B-GENE	NOUN	B
alpha	I-GENE	NOUN	O
dephosphoform	O	NOUN	B
(	O	PUNCT	O
51	O	NUM	O
kDa	O	NOUN	O
)	O	PUNCT	O
greater	O	ADJ	O
than	O	ADP	O
RI	B-GENE	NOUN	B
alpha	I-GENE	NOUN	I
(	O	PUNCT	O
49	O	NUM	O
kDa	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


Within	O	ADP	O
the	O	DET	O
human	O	ADJ	B
enhancer	O	NOUN	O
,	O	PUNCT	O
these	O	DET	O
two	O	NUM	O
sites	O	NOUN	B
are	O	AUX	O
located	O	ADJ	O
within	O	ADP	O
the	O	DET	O
previously	O	ADV	O
defined	O	VERB	O
DNase	B-GENE	NOUN	B
I	I-GENE	NUM	I
footprints	I-GENE	NOUN	B
,	O	PUNCT	O
NFAT	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
and	O	CCONJ	O
NFIL	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2B	I-GENE	PROPN	B
,	O	PUNCT	O
respectively	O	ADV	O
.	O	PUNCT	O


The	O	DET	O
cardiac	B-GENE	ADJ	B
myosin	I-GENE	NOUN	I
light	I-GENE	ADJ	I
chain	I-GENE	NOUN	I
-	I-GENE	SYM	O
2	I-GENE	NUM	O
(	O	PUNCT	O
MLC	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
)	O	PUNCT	O
gene	O	NOUN	B
promoter	O	NOUN	I
contains	O	VERB	O
several	O	ADJ	O
positive	O	ADJ	B
and	O	CCONJ	O
negative	O	ADJ	B
cis	O	ADV	O
-	O	PUNCT	O
acting	O	VERB	B
sequences	O	NOUN	B
that	O	PRON	O
are	O	AUX	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
regulation	O	NOUN	B
of	O	ADP	O
its	O	PRON	O
expression	O	NOUN	B
.	O	PUNCT	O


Disruption	O	NOUN	B
mutations	O	NOUN	O
have	O	AUX	O
been	O	AUX	O
constructed	O	VERB	O
in	O	ADP	O
the	O	DET	O
SLK1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O
slk1	B-GENE	NOUN	B
null	I-GENE	ADJ	B
mutants	I-GENE	NOUN	I
cannot	O	VERB	B
grow	O	VERB	I
at	O	ADP	O
37	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I
,	O	PUNCT	O
but	O	CCONJ	O
many	O	ADJ	O
cells	O	NOUN	B
can	O	AUX	O
grow	O	VERB	B
at	O	ADP	O
30	O	NUM	O
,	O	PUNCT	O
24	O	NUM	O
,	O	PUNCT	O
and	O	CCONJ	O
17	O	NUM	O
degrees	O	NOUN	B
C	O	NOUN	I
.	O	PUNCT	O


A	O	DET	O
32P	O	NOUN	B
-	O	PUNCT	O
labeled	O	VERB	B
LAP	B-GENE	NOUN	B
DNA	O	NOUN	B
-	O	PUNCT	O
binding	O	NOUN	B
and	O	CCONJ	O
dimerization	O	NOUN	B
domain	O	NOUN	I
"	O	PUNCT	O
zipper	O	NOUN	B
probe	O	NOUN	I
"	O	PUNCT	O
was	O	AUX	O
used	O	VERB	O
to	O	PART	O
isolate	O	VERB	B
a	O	DET	O
clone	O	NOUN	B
that	O	PRON	O
encodes	O	VERB	B
a	O	DET	O
new	O	ADJ	O
C	B-GENE	NOUN	B
/	I-GENE	PUNCT	O
EBP	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
homologous	I-GENE	ADJ	B
protein	I-GENE	NOUN	I
:	O	PUNCT	O
CHOP	B-GENE	NOUN	B
-	I-GENE	SYM	O
10	I-GENE	NUM	O
.	O	PUNCT	O


Stringent	O	ADJ	B
hybridization	O	NOUN	I
of	O	ADP	O
EHS	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
back	O	NOUN	O
to	O	PART	O
primate	O	ADJ	B
genomic	O	ADJ	B
DNA	O	NOUN	I
indicates	O	VERB	O
two	O	NUM	O
distinct	O	ADJ	O
EHS	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	B
loci	I-GENE	NOUN	B
in	O	ADP	O
normal	O	ADJ	O
human	O	ADJ	B
DNA	O	NOUN	B
,	O	PUNCT	O
an	O	DET	O
identical	O	ADJ	B
band	O	NOUN	B
pattern	O	NOUN	I
in	O	ADP	O
chimpanzee	O	NOUN	B
DNA	O	NOUN	I
,	O	PUNCT	O
and	O	CCONJ	O
a	O	DET	O
single	O	ADJ	O
locus	O	NOUN	O
in	O	ADP	O
rhesus	O	NOUN	B
monkey	O	NOUN	I
DNA	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
Caenorhabditis	B-GENE	NOUN	B
elegans	I-GENE	X	I
vitellogenin	I-GENE	NOUN	B
genes	I-GENE	NOUN	I
are	O	AUX	O
subject	O	ADJ	O
to	O	ADP	O
sex	O	NOUN	B
-	O	PUNCT	O
,	O	PUNCT	O
stage	O	NOUN	B
-	O	PUNCT	O
,	O	PUNCT	O
and	O	CCONJ	O
tissue	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
regulation	O	NOUN	B
:	O	PUNCT	O
they	O	PRON	O
are	O	AUX	O
expressed	O	VERB	B
solely	O	ADV	O
in	O	ADP	O
the	O	DET	O
adult	O	ADJ	B
hermaphrodite	O	ADJ	B
intestine	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
c	B-GENE	X	B
-	I-GENE	PUNCT	O
Ets	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
1	I-GENE	NUM	O
oncoprotein	I-GENE	NOUN	B
is	O	AUX	O
a	O	DET	O
transcription	O	NOUN	B
activator	O	NOUN	I
that	O	PRON	O
specifically	O	ADV	O
binds	O	VERB	B
to	O	PART	O
DNA	O	NOUN	B
.	O	PUNCT	O


Hence	O	ADV	O
temperature	O	NOUN	B
and	O	CCONJ	O
virF	B-GENE	NOUN	B
are	O	AUX	O
both	O	DET	O
required	O	VERB	O
for	O	ADP	O
the	O	DET	O
induction	O	NOUN	B
of	O	ADP	O
the	O	DET	O
yop	B-GENE	NOUN	B
regulon	I-GENE	NOUN	I
.	O	PUNCT	O


To	O	PART	O
determine	O	VERB	O
the	O	DET	O
genetic	O	ADJ	B
basis	O	NOUN	O
for	O	ADP	O
the	O	DET	O
differences	O	NOUN	B
between	O	ADP	O
the	O	DET	O
cardiac	O	ADJ	B
and	O	CCONJ	O
brain	B-GENE	NOUN	B
AE3	I-GENE	NOUN	B
variants	I-GENE	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
isolated	O	VERB	B
and	O	CCONJ	O
characterized	O	VERB	B
the	O	DET	O
rat	O	NOUN	B
gene	O	NOUN	B
.	O	PUNCT	O


Lac	B-GENE	NOUN	B
operators	O	NOUN	I
were	O	AUX	O
introduced	O	VERB	O
into	O	ADP	O
several	O	ADJ	O
positions	O	NOUN	B
within	O	ADP	O
the	O	DET	O
CAB	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
and	O	CCONJ	O
operator	O	NOUN	B
-	O	PUNCT	O
free	O	ADJ	B
plasmid	O	NOUN	O
was	O	AUX	O
used	O	VERB	O
as	O	ADP	O
control	O	NOUN	B
.	O	PUNCT	O


The	O	DET	O
SEN1	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
corresponds	O	VERB	O
to	O	PART	O
a	O	DET	O
6	O	NUM	O
,	O	PUNCT	O
336	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
coding	O	VERB	I
for	O	ADP	O
a	O	DET	O
2	O	NUM	O
,	O	PUNCT	O
112	O	NUM	O
-	O	PUNCT	O
amino	O	NOUN	B
-	O	PUNCT	O
acid	O	NOUN	B
protein	O	NOUN	I
(	O	PUNCT	O
molecular	O	ADJ	B
mass	O	NOUN	I
,	O	PUNCT	O
239	O	NUM	O
kDa	O	NOUN	O
)	O	PUNCT	O
.	O	PUNCT	O


The	O	DET	O
IA4	B-GENE	NOUN	B
mAb	I-GENE	NOUN	B
was	O	AUX	O
identified	O	VERB	B
among	O	ADP	O
a	O	DET	O
series	O	NOUN	B
of	O	ADP	O
antibodies	O	NOUN	B
raised	O	VERB	O
in	O	ADP	O
BALB	O	NOUN	B
/	O	SYM	O
c	O	NOUN	B
mice	O	NOUN	B
after	O	ADP	O
immunization	O	NOUN	B
against	O	ADP	O
a	O	DET	O
HLA	B-GENE	NOUN	B
class	O	NOUN	I
I	O	NUM	I
-	O	PUNCT	O
deficient	O	ADJ	B
,	O	PUNCT	O
lymphokine	O	NOUN	B
-	O	PUNCT	O
activated	O	VERB	B
killer	O	NOUN	I
(	O	PUNCT	O
LAK	O	NOUN	B
)	O	PUNCT	O
-	O	PUNCT	O
susceptible	O	ADJ	B
EBV	O	NOUN	B
-	O	PUNCT	O
B	O	NOUN	B
lymphocyte	O	NOUN	I
line	O	NOUN	I
.	O	PUNCT	O


Primer	O	NOUN	B
extension	O	NOUN	B
and	O	CCONJ	O
mung	B-GENE	NOUN	B
bean	I-GENE	NOUN	I
and	I-GENE	CCONJ	O
S1	I-GENE	NOUN	B
nuclease	I-GENE	NOUN	I
mapping	O	NOUN	I
indicated	O	VERB	O
multiple	O	ADJ	B
transcription	O	NOUN	O
initiation	O	NOUN	O
sites	O	NOUN	O
and	O	CCONJ	O
were	O	AUX	O
consistent	O	ADJ	B
with	O	ADP	I
Northern	O	NOUN	B
analyses	O	NOUN	I
.	O	PUNCT	O


PSI	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
G	I-GENE	NOUN	B
and	O	CCONJ	O
PSI	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
K	I-GENE	PROPN	B
probably	O	ADV	O
have	O	AUX	O
evolved	O	VERB	O
from	O	ADP	O
a	O	DET	O
gene	O	NOUN	B
duplication	O	NOUN	I
of	O	ADP	O
an	O	DET	O
ancestral	O	ADJ	B
gene	O	NOUN	I
.	O	PUNCT	O


An	O	DET	O
experiment	O	NOUN	B
examined	O	VERB	O
the	O	DET	O
effects	O	NOUN	B
of	O	ADP	I
treatment	O	NOUN	B
with	O	ADP	O
gonadotrophin	B-GENE	NOUN	B
releasing	I-GENE	NOUN	I
hormone	I-GENE	NOUN	I
(	O	PUNCT	O
100	O	NUM	O
micrograms	O	NOUN	O
GnRH	B-GENE	NOUN	B
injected	O	VERB	B
24	O	NUM	O
h	O	NOUN	O
after	O	ADP	O
progestagen	O	NOUN	B
sponge	O	NOUN	O
removal	O	NOUN	O
)	O	PUNCT	O
,	O	PUNCT	O
season	O	NOUN	B
of	O	ADP	O
treatment	O	NOUN	B
(	O	PUNCT	O
autumn	O	NOUN	B
v	O	NOUN	O
.	O	PUNCT	O
spring	O	NOUN	B
)	O	PUNCT	O
,	O	PUNCT	O
the	O	DET	O
effect	O	NOUN	B
of	O	ADP	O
supplementary	O	ADJ	O
feeding	O	NOUN	B
with	O	ADP	O
lupin	O	NOUN	B
grain	O	NOUN	I
(	O	PUNCT	O
in	O	ADP	O
autumn	O	NOUN	B
only	O	ADV	O
,	O	PUNCT	O
from	O	ADP	O
12	O	NUM	O
days	O	NOUN	B
before	O	ADV	O
until	O	ADP	O
8	O	NUM	O
days	O	NOUN	B
after	O	ADP	O
sponge	O	NOUN	B
removal	O	NOUN	I
)	O	PUNCT	O
on	O	ADP	O
the	O	DET	O
time	O	NOUN	B
of	O	ADP	O
ovulation	O	NOUN	B
in	O	ADP	O
182	O	NUM	O
mature	O	ADJ	B
Merino	O	NOUN	B
ewes	O	NOUN	B
superovulated	O	VERB	B
with	O	ADP	O
a	O	DET	O
combination	O	NOUN	B
of	O	ADP	O
400	O	NUM	O
I	O	NOUN	O
.	O	PUNCT	O
U	O	NOUN	O
.	O	PUNCT	O
pregnant	B-GENE	ADJ	B
mare	I-GENE	NOUN	I
serum	I-GENE	NOUN	B
gonadotrophin	I-GENE	NOUN	I
(	O	PUNCT	O
PMSG	B-GENE	NOUN	B
)	O	PUNCT	O
and	O	CCONJ	O
12	O	NUM	O
mg	O	NOUN	O
follicle	B-GENE	NOUN	B
stimulating	I-GENE	NOUN	O
hormone	I-GENE	NOUN	O
(	O	PUNCT	O
FSH	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
P	I-GENE	NOUN	B
)	O	PUNCT	O
.	O	PUNCT	O


STP1	B-GENE	NOUN	B
is	O	AUX	O
an	O	DET	O
unessential	O	ADJ	O
yeast	O	NOUN	B
gene	O	NOUN	O
involved	O	VERB	O
in	O	ADP	O
the	O	DET	O
removal	O	NOUN	B
of	O	ADP	O
intervening	O	VERB	O
sequences	O	NOUN	O
from	O	ADP	O
some	O	DET	O
,	O	PUNCT	O
but	O	CCONJ	O
not	O	PART	O
all	O	DET	O
,	O	PUNCT	O
families	O	NOUN	B
of	O	ADP	O
intervening	O	VERB	O
sequence	O	NOUN	B
-	O	PUNCT	O
containing	O	VERB	B
pre	O	ADJ	B
-	O	PUNCT	O
tRNAs	O	NOUN	B
.	O	PUNCT	O


Using	O	VERB	O
these	O	DET	O
antibodies	O	NOUN	B
,	O	PUNCT	O
we	O	PRON	O
were	O	AUX	O
able	O	ADJ	O
to	O	PART	O
define	O	VERB	O
the	O	DET	O
conditions	O	NOUN	B
to	O	PART	O
completely	O	ADV	O
solubilize	O	VERB	B
the	O	DET	O
Cdc25	B-GENE	NOUN	B
protein	I-GENE	NOUN	I
.	O	PUNCT	O


Disruption	O	NOUN	B
demonstrates	O	VERB	O
that	O	SCONJ	O
CDC14	B-GENE	NOUN	B
is	O	AUX	O
an	O	DET	O
essential	O	ADJ	B
gene	O	NOUN	I
.	O	PUNCT	O


Argatroban	O	PROPN	B
may	O	AUX	O
be	O	AUX	O
more	O	ADV	O
effective	O	ADJ	B
under	O	ADP	O
low	O	ADJ	B
HC	B-GENE	NOUN	B
II	I-GENE	NUM	I
conditions	O	NOUN	B
because	O	SCONJ	O
of	O	ADP	O
its	O	PRON	O
potent	O	ADJ	O
inhibition	O	NOUN	B
of	O	ADP	O
thrombin	B-GENE	NOUN	B
activity	O	NOUN	I
at	O	ADP	O
sites	O	NOUN	B
of	O	ADP	O
vascular	O	ADJ	B
wall	O	NOUN	I
damage	O	NOUN	I
.	O	PUNCT	O


Furthermore	O	ADV	O
,	O	PUNCT	O
no	O	DET	O
transcripts	O	NOUN	B
of	O	ADP	O
the	O	DET	O
same	O	ADJ	O
size	O	NOUN	B
and	O	CCONJ	O
having	O	VERB	O
the	O	DET	O
same	O	ADJ	O
developmental	O	ADJ	B
profile	O	NOUN	I
as	O	ADP	O
those	O	DET	O
generated	O	VERB	O
by	O	ADP	O
the	O	DET	O
wild	B-GENE	ADJ	B
-	I-GENE	PUNCT	O
type	I-GENE	NOUN	B
E10	I-GENE	NOUN	O
fragment	I-GENE	NOUN	O
were	O	AUX	O
identified	O	VERB	B
by	O	ADP	O
probes	O	NOUN	B
covering	O	VERB	O
the	O	DET	O
remainder	O	NOUN	O
of	O	ADP	O
the	O	DET	O
cloned	O	VERB	B
region	O	NOUN	O
.	O	PUNCT	O


The	O	DET	O
sequence	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
interaction	O	NOUN	B
of	O	ADP	O
nuclear	B-GENE	ADJ	B
factor	I-GENE	NOUN	I
HiNF	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
D	I-GENE	NOUN	B
with	O	ADP	O
this	O	DET	O
key	O	ADJ	O
proximal	O	ADJ	B
promoter	O	NOUN	B
element	O	NOUN	I
of	O	ADP	O
the	O	DET	O
H4	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
FO108	I-GENE	NOUN	B
gene	I-GENE	NOUN	I
is	O	AUX	O
cell	O	NOUN	B
cycle	O	NOUN	I
regulated	O	VERB	O
in	O	ADP	O
normal	O	ADJ	B
diploid	O	ADJ	I
cells	O	NOUN	I
(	O	PUNCT	O
J	O	NOUN	O
.	O	PUNCT	O


In	O	ADP	O
agreement	O	NOUN	O
with	O	ADP	O
this	O	DET	O
southern	O	ADJ	B
blotting	O	NOUN	I
of	O	ADP	O
mouse	O	NOUN	B
DNA	O	NOUN	I
with	O	ADP	O
SmN	B-GENE	NOUN	B
probes	O	NOUN	I
reveals	O	VERB	O
bands	O	NOUN	O
,	O	PUNCT	O
additional	O	ADJ	O
to	O	PART	O
those	O	DET	O
derived	O	VERB	O
from	O	ADP	O
the	O	DET	O
pseudogene	O	NOUN	B
,	O	PUNCT	O
which	O	DET	O
are	O	AUX	O
characteristic	O	ADJ	O
of	O	ADP	O
an	O	DET	O
intron	O	NOUN	B
-	O	PUNCT	O
containing	O	VERB	B
SmN	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
.	O	PUNCT	O


A	O	DET	O
38	O	NUM	O
-	O	PUNCT	O
bp	O	NOUN	B
poly	O	NOUN	B
(	O	PUNCT	I
dA	O	NOUN	B
-	O	PUNCT	O
dT	O	NOUN	B
)	O	PUNCT	O
region	O	NOUN	O
was	O	AUX	O
found	O	VERB	O
to	O	PART	O
be	O	AUX	O
a	O	DET	O
positive	O	ADJ	O
regulator	O	NOUN	B
of	O	ADP	O
Act1	B-GENE	NOUN	B
promoter	I-GENE	NOUN	B
activity	O	NOUN	I
.	O	PUNCT	O


The	O	DET	O
DRF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
nuclear	I-GENE	ADJ	I
protein	I-GENE	NOUN	I
has	O	AUX	O
characteristics	O	NOUN	B
similar	O	ADJ	O
to	O	PART	O
those	O	DET	O
of	O	ADP	O
the	O	DET	O
muscle	O	NOUN	B
-	O	PUNCT	O
specific	O	ADJ	B
regulatory	O	ADJ	B
factor	O	NOUN	I
,	O	PUNCT	O
MEF	B-GENE	PROPN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	O
(	O	PUNCT	O
Buskin	O	PROPN	B
and	O	CCONJ	O
Hauschka	O	PROPN	O
1989	O	NUM	O
;	O	PUNCT	O
Gossett	O	PROPN	O
et	O	X	O
al	O	X	O
.	O	PUNCT	O
,	O	PUNCT	O
1989	O	NUM	O
)	O	PUNCT	O
.	O	PUNCT	O


From	O	ADP	O
the	O	DET	O
15	O	NUM	O
-	O	PUNCT	O
kb	O	NOUN	O
clone	O	NOUN	B
a	O	DET	O
4	B-GENE	NUM	O
-	I-GENE	PUNCT	O
kb	I-GENE	NOUN	B
EcoRI	I-GENE	NOUN	I
fragment	I-GENE	NOUN	I
containing	O	VERB	O
the	O	DET	O
first	O	ADJ	O
two	O	NUM	O
exons	O	NOUN	B
and	O	CCONJ	O
2	O	NUM	O
.	O	PUNCT	O
6	O	NUM	O
kb	O	NOUN	O
of	O	ADP	O
the	O	DET	O
5	O	NUM	O
'	O	PART	O
flanking	O	ADJ	B
region	O	NOUN	I
of	O	ADP	O
the	O	DET	O
opn	B-GENE	NOUN	B
gene	I-GENE	NOUN	I
was	O	AUX	O
sequenced	O	VERB	B
,	O	PUNCT	O
and	O	CCONJ	O
the	O	DET	O
transcriptional	O	ADJ	B
start	O	NOUN	O
site	O	NOUN	O
determined	O	VERB	O
by	O	ADP	O
primer	O	NOUN	B
extension	O	NOUN	I
analysis	O	NOUN	I
and	O	CCONJ	O
S1	B-GENE	NOUN	B
nuclease	I-GENE	NOUN	I
mapping	O	NOUN	I
.	O	PUNCT	O


This	O	DET	O
open	O	ADJ	B
reading	O	NOUN	I
frame	O	NOUN	I
was	O	AUX	O
confirmed	O	VERB	O
the	O	DET	O
correct	O	ADJ	O
one	O	NUM	O
by	O	ADP	O
direct	O	ADJ	O
amino	O	NOUN	B
-	O	PUNCT	O
terminal	O	ADJ	B
sequence	O	NOUN	B
analysis	O	NOUN	I
of	O	ADP	O
the	O	DET	O
overproduced	O	VERB	B
msgB	B-GENE	NOUN	B
gene	I-GENE	NOUN	B
product	I-GENE	NOUN	I
.	O	PUNCT	O


The	O	DET	O
virus	O	NOUN	B
encodes	O	VERB	B
a	O	DET	O
40	O	NUM	O
-	O	PUNCT	O
kDa	O	NOUN	B
protein	O	NOUN	I
,	O	PUNCT	O
tax	B-GENE	NOUN	O
,	O	PUNCT	O
that	O	PRON	O
is	O	AUX	O
important	O	ADJ	O
for	O	ADP	O
the	O	DET	O
immortalization	O	NOUN	B
of	O	ADP	O
T	O	NOUN	B
cells	O	NOUN	I
.	O	PUNCT	O


However	O	ADV	O
,	O	PUNCT	O
butyrate	O	NOUN	B
was	O	AUX	O
at	O	ADP	O
least	O	ADV	O
2	O	NUM	O
-	O	PUNCT	O
fold	O	VERB	B
more	O	ADV	O
effective	O	ADJ	B
in	O	ADP	O
stimulating	O	VERB	B
CAT	B-GENE	NOUN	B
activity	O	NOUN	I
of	O	ADP	O
fusion	O	NOUN	B
genes	O	NOUN	I
containing	O	VERB	O
upstream	O	ADJ	B
sequences	O	NOUN	I
(	O	PUNCT	O
-	O	PUNCT	O
834	O	NUM	O
to	O	ADP	O
-	O	PUNCT	O
576	O	NUM	O
)	O	PUNCT	O
than	O	ADP	O
those	O	DET	O
containing	O	VERB	O
proximal	O	ADJ	B
sequences	O	NOUN	I
(	O	PUNCT	O
-	O	PUNCT	O
456	O	NUM	O
to	O	PART	O
-	O	PUNCT	O
172	O	NUM	O
)	O	PUNCT	O
,	O	PUNCT	O
suggesting	O	VERB	O
two	O	NUM	O
regions	O	NOUN	B
in	O	ADP	O
the	O	DET	O
PSG1	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
I	I-GENE	NOUN	B
gene	I-GENE	NOUN	B
that	O	PRON	O
mediate	O	VERB	O
the	O	DET	O
butyrate	O	NOUN	B
response	O	NOUN	I
.	O	PUNCT	O


Recently	O	ADV	O
,	O	PUNCT	O
the	O	DET	O
3	B-GENE	NUM	O
.	I-GENE	PUNCT	O
6	I-GENE	NUM	O
-	I-GENE	PUNCT	O
kb	I-GENE	NOUN	O
full	I-GENE	ADJ	B
-	I-GENE	PUNCT	O
length	I-GENE	NOUN	B
alpha	I-GENE	NOUN	B
-	I-GENE	PUNCT	O
GalNAc	I-GENE	NOUN	B
cDNA	I-GENE	NOUN	B
sequence	I-GENE	NOUN	I
was	O	AUX	O
isolated	O	VERB	B
and	O	CCONJ	O
found	O	VERB	O
to	O	PART	O
have	O	AUX	O
remarkable	O	ADJ	O
nucleotide	O	NOUN	B
and	O	CCONJ	O
predicted	O	VERB	B
amino	O	NOUN	B
acid	O	NOUN	I
homology	O	NOUN	I
(	O	PUNCT	O
55	O	NUM	O
.	O	PUNCT	O
8	O	NUM	O
and	O	CCONJ	O
46	O	NUM	O
.	O	PUNCT	O
9	O	NUM	O
%	O	NOUN	O
,	O	PUNCT	O
respectively	O	ADV	O
)	O	PUNCT	O
with	O	ADP	O
the	O	DET	O
human	B-GENE	ADJ	B
alpha	I-GENE	NOUN	I
-	I-GENE	PUNCT	O
galactosidase	I-GENE	NOUN	B
A	I-GENE	NOUN	I
(	O	PUNCT	O
alpha	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
Gal	I-GENE	PROPN	B
A	I-GENE	NOUN	I
)	O	PUNCT	O
cDNA	O	NOUN	B
.	O	PUNCT	O


All	O	DET	O
mutant	B-GENE	ADJ	B
JCV	I-GENE	NOUN	B
T	I-GENE	NOUN	B
antigens	I-GENE	NOUN	I
bound	O	VERB	O
to	O	PART	O
JCV	O	NOUN	B
and	O	CCONJ	O
SV40	O	NOUN	B
origins	O	NOUN	B
of	O	ADP	O
DNA	O	NOUN	B
replication	O	NOUN	I
.	O	PUNCT	O


EBNA	B-GENE	NOUN	B
-	I-GENE	PUNCT	O
2	I-GENE	NUM	B
and	O	CCONJ	O
the	O	DET	O
cis	O	ADV	B
-	O	PUNCT	O
acting	O	VERB	B
CD23	B-GENE	NOUN	B
element	I-GENE	NOUN	B
increased	O	VERB	B
TK	B-GENE	NOUN	B
-	O	PUNCT	O
promoted	O	VERB	B
mRNA	O	NOUN	B
and	O	CCONJ	O
did	O	AUX	O
not	O	PART	O
alter	O	VERB	O
the	O	DET	O
herpes	B-GENE	NOUN	B
simplex	I-GENE	NOUN	I
virus	I-GENE	NOUN	I
TK	I-GENE	NOUN	B
promoter	I-GENE	NOUN	B
transcription	I-GENE	NOUN	I
start	I-GENE	NOUN	I
site	I-GENE	NOUN	I
.	O	PUNCT	O


